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Abstract 
Members of the MAF (proto-) oncogene and CNC families of basic leucine zipper transcription 
factors (bZIP) play important roles in development, differentiation, mammalian gene 
expression and stress signalling. We analyzed the regulation of the human small MAF 
transcription factor family members, MAFF, MAFG and MAFK, as weIl as two CNe family 
members, NRF2 and NRF3, in human reproductive tissue. We found that MAFF expression 
was induced by the proinflammatory cytokines interleukin 1 beta (ILIB) and tumor necrosis 
factor (TNF) in PHMI-31 myometrial cells. It was particularly interesting that the 
proinflammatory cytokine Interleukin 6 not affect the expression of MAFF. AdditionaIly, the 
transcript and protein levels of the highly homologous MAFG and MAFK genes were not 
modulated by these cytokines. Using electromobility shift assays (EMSA)s we showed that 
MAFF is capable of heterodimerzing with NRF3, and since they are both highly expressed in 
the placenta we investigated their role in more detail in this tissue. We found that MAFF and 
NRF3 are expressed in the anchoring villi from 12 weeks to term. Furthermore, we 
demonstrated that MAFF and NRF3 are highly expressed in primary placental 
cytotrophoblasts, but not in placental fibroblasts. This led us to examine whether NRF3 is also 
regulated by proinflammatory cytokines and we showed that NRF3, is also modulated by TNF 
in the human JAR placental ceIlline. 
Parallel studies investigated the role NRF2 plays in the antioxidant response of placental cells 
due to exposure to arsenic. We provided evidence for the involvement of NRF2 by confirming 
the increase in binding of endogenous NRF2/small MAF heterodimers to Stress Response 
Element (StRE), and the upregulation of heme oxygenase-l (HOI) expression, upon exposure 
of JAR cells to arsenic. Our results suggest a role for MAFF, NRF3 and NRF2 10 
proinflammatory cytokine control of myometrial and placental gene expression as weIl as 
arsenic mediated stress in placental cells. 
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Résumé 
Les facteurs de transcription à domaine leucine basique zipper (bZip) appartenant aux familles 
Maf (proto-)oncogènes et Cap 'n' Collar (CNC) sont des régulateurs clés du développement, 
de la différenciation, de l'expression génique chez les mammifères et de la réponse au stress. 
Nous avons analysé la régulation des membres de la famille des facteurs de transcription des 
petits MAF (MAFF, MAFG et MAFK) et nous avons également analysé la régulation de deux 
membres de la famille CNC (NRF2 et NRF3) dans l'organe reproducteur humain. Nous avons 
trouvé que l'expression de MAFF est induit par l'interleukine 1 béta (ILIB), une cytokine 
proinflammatoire et par le facteur de nécrose tumorale (TNF) dans les cellules de myomètres. 
De manière intéressante, l'interleukine 6, une autre cytokine proinflammatoire, n'affecte pas 
l'expression de MAFF et les deux cytokines (ILIB et IL6) n'ont pas d'effet sur les niveaux de 
transcrits et de protéines des gènes homologues MAFG et MAFK. En utilisant la technique de 
retard sur gel (EMSA), nous avons montré que MAFF est capable de s'hétérodimériser avec 
NRF3, et comme les deux facteurs de transcription sont hautement exprimés dans le placenta 
nous avons étudié leurs rôles de manière plus approfondie. Nous avons trouvé que MAFF et 
NRF3 sont exprimés dans la partie ancrée du villus dès la 12è semaine de grossesse et ce 
jusqu'à la naissance. De plus, nous avons démontré que MAFF et NRF3 sont hautement 
exprimés dans le cytotrophoblaste placentaire primaire mais pas dans les fibroblastes 
placentaires. Ceci nous a mené à examiner si NRF3 est aussi régulé par les cytokines 
proinflammatoires et nous avons montré que NRF3 est également modulé par TNF dans la 
lignée JAR de cellules placentaires humaines. 
En parallèle, nous avons étudié le rôle joué par NRF2 dans la réponse antioxidante des cellules 
placentaires à une exposition à l'arsenic. Nous avons clairement montré l'implication de NRF2 
en confirmant l'augmentation de fixation des hétérodimères endogènes NRF2/petit MAF aux 
Eléments de Réponse au Stress (<< Stress Response Element»: StRE), et l'augmentation de 
l'expression de l'hème oxygénase-l (HO 1), en réponse à l'arsenic dans les cellules JAR. Nos 
résultats suggèrent un rôle pour MAFF, NRF3 et NRF2 dans le contrôle des cytokines 
proinflammatoires de l'expression des gènes placentaires et myométriaux et également dans le 
stress induit par l'arsenic dans les cellules placentaires. 
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Preface 
ln accordance with the "Guidelines for Thesis Preparation", the candidate has chosen to 
present the results of his thesis in classical fOfIll. A general introduction is presented in Chapter 
1 and appears, in part, in the following journal articles following the subjection to the peer 
review process; an asterix (*) denotes publications for which the indicated authors contributed 
equally: 
1. Functional and Placental Expression Analysis of the Human NRF3 Transcription 
Factor. BenOIt Chenais*, Anna Derjuga*, Wael Massrieh*, Kristy Red-Horse, Valerie 
Bellingard, Susan J. Fisher, and Volker Blank. * [Co-First Authors]. Molecular 
Endocrinology. 2005 Jan; 19(1): 125-37. Epub 2004 Sep 23. 
2. Regulation of the MAFF Transcription Factor by Proinflammatory Cytokines in 
Myometrial Cells. Massrieh W, Derjuga A, Doualla-Bell F, Ku CY, Sanborn BM, 
Blank V. Biology of Reproduction. 2006 Apr;74(4):699-705. 2005 Dec 21. 
3. Induction of Endogenous NRF2/small MAF Heterodimers by Arsenic-Mediated 
Stress in Placental Choriocarcinoma Cells. Massrieh W, Derjuga A, Blank V. 
Antioxidant and Redox Signalling. 2006 Jan-Feb; 8(1-2):53-9. 
Materials and methods for research presented in this document are detailed in chapter II. The 
results described in chapter III, IV, and V have been published, in part, in the following journal 
articles following the subjection to the peer review process; an asterix (*) denotes publications 
for which the indicated authors contributed equally: 
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4. Functional and Placental Expression Analysis of the Human NRF3 Transcription 
Factor. BenOIt Chenais*, Anna DeIjuga*, Wael Massrieh*, Kristy Red-Horse, Valerie 
Bellingard, Susan J. Fisher, and Volker Blank. * [Co-First Authors]. Molecular 
Endocrinology. 2005 Jan;19(1):125-37. Epub 2004 Sep 23. 
5. Regulation of the MAFF Transcription Factor by Proinflammatory Cytokines in 
Myometrial Cells. Massrieh W, Derjuga A, Doualla-Bell F, Ku CY, Sanborn BM, 
Blank V. Biology of Reproduction. 2006 Apr;74(4):699-705. 2005 Dec 21. 
6. Induction of Endogenous NRF2Ismall MAF Heterodimers by Arsenic-Mediated 
Stress in Placental Choriocarcinoma Cells. Massrieh W*, DeIjuga A *, Blank V. * 
[Co-First Authors]. Antioxidants and Redox Signalling. 2006 Jan-Feb; 8(1-2):53-9. 
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CHAPTERI 
A. Transcription Factor Families 
Gene regulation gives the cell control over structure and function, and is the basis for cellular 
differentiation, morphogenesis and the versatility and adaptability of any organism [1]. 
Initiation of messenger RNA (mRNA) synthesis by RNA polymerase II is a primary control 
point in the regulation of differential gene expression. It is clear that the frequency of initiation 
of mRNA synthesis depends ultimately on factors that interact with the specific "nuclear 
messengers" in gene promoters [2, 3]. The analysis of these nuclear messengers has shed light 
on the final steps in cellular signal transduction and has thus offered a novel approach to 
tracing the critical events by starting at the end and working backwards. 
CIues to the biological processes in which the se nuclear messengers participate may be 
obtained by determining their tissue expression patterns, elucidating their DNA binding 
specificities [4] or mapping their chromosomal sites of occupancy [5]. Ultimately, 
understanding the function of a transcriptional activator will require identification of the genes 
that it controls. This requires derivation of appropriate celllines or animal models in which the 
protein can be expressed (or inactivated) in a regulated fashion. The consequences of its 
expression (or inactivation) on the transcription of specific genes is then monitored. In the most 
powerful version of this approach, target gene transcription can be assayed in parallel using 
high-density DNA microarrays [6]. 
Factors involved in the transcription of eukaryotic protein-coding genes by RNA polymerase II 
fall into two groups: 
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a) General transcription factors, which are involved in the formation of the preinitiation 
complex (PIC). The most common are abbreviated as TFIIA, TFIID, TFIID, TFIIE, TFIIF, and 
TFIIH. They are ubiquitous and along with RNA Polymerase II they interact with the core 
promoter region and specify the transcription start site. PIC formation usually begins with 
TFIID binding to the TA TA box found in most core promoters, followed by the entry of other 
general transcription factors and RNA Polymerase II through either a sequential assembly or a 
preassembled RNA Polymerase II holoenzyme pathway. [3J 
b) Inducible transcription factors (signal regulated transcription factors) bind upstream or 
downstream of the initiation site and require activation or inhibition to transmit regulatory 
signaIs between gene-specifie activators and the general transcription machinery [3]. 
Transcription factors often are classified according to the type of DNA-binding domain they 
contain. Most of the structural classes of DNA-binding domains have characteristic consensus 
amino acid sequences. A few of the more common classes of DNA-binding domains whose 
three-dimensional structures have been determined are described here. 
1. Transcription Factor DNA binding motifs 
1.1 Helix-Turn-helix (HTH) 
The HTH family of transcription factors DNA binding motif is composed of two a helices 
joined by a short strand of amino acids (Fig. lA) [7]. In particular, recognition and binding to 
DNA is done by the two a helices, one occupying the N-terminal end of the motif, the other at 
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Fig.1 A) Helix-turn-helix transcription factors. Structure is composed of two 
alpha helices joined by a short strand of amino acids. The first helix contributes 
most to DNA recognition, and hence it is called the "recognition helix". The 
second u helix stabilizes the interaction between protein and DNA [8]. B) Zinc 
linger transcription factors. Structure consists of two antiparallel beta strands, 
and an alpha helix. A sub-set of zinc-fingers comprise a pair of cysteine 
residues in the beta sheets and two histidine residues in the alpha helix which 
are responsible for binding a zinc atom. The u-helix occurs at the C-terminal 
part of the finger, whilst the beta sheet occurs at the N-terminal part [9]. C) 
Helix-Ioop-Helix transcription factors. Structure is characterised by two alpha 
helices connected by a loop. The longer helix contains basic amino acid residues 
that facilitate DNA binding. The smaller helix typically allows dimerization by 
folding and packing against the longer helix [10]. 
- 23-
o 
-
- 24-
2_+-..., 
3 
/ N 
. :;, 
III 
-
the C-terminus [7]. In most cases, the first helix contributes most to DNA recognition and 
hence it is often called the "recognition helix". 
1.2 Zinc Finger 
The zinc finger family consists of two antiparallel ~ strands, and an a helix (Fig. lB). They 
were originally identified as DNA binding structures in the RNA polymerase III transcription 
factor TFllIA, which binds to the internaI control region of the 5S RNA gene [11]. 
1.3 Helix-Loop-Helix (HLH) 
This family of transcription factors is characterized by two a helices connected by a loop (Fig. 
1 C). One helix is typically smaller and due to the flexibility of the loop, allows dimerization by 
folding and packing against another helix [12]. 
1.4 Basic-Leucine Zippers (BZIP) 
The 3D structure of bZIP proteins consists of three a-helices [13]. The most striking feature of 
this family of indu cible transcription factors is the presence of the basic leucine zipper (bZIP) 
domain at the carboxyl terminus (Fig. 2A) [14]. One region of this domain facilitates 
dimerization and the other contacts DNA. The dimer-forming region, termed the "leucine 
zipper" is formed by heptad repeats of leucine residues (LLLMLL or LLLLYL) [15] (Fig. 2A). 
Since there are 3.6 residues/turn in an a-helix, this positions one leucine at every second turn, 
just short of being exactly under each other in the coiI. These leucines were shown to form the 
hydrophobic core of a coiled coiI [16] which extends away from the DNA in a direction 
perpendicular to the overall DNA helix axis [17]. 
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The DNA binding region, termed the basic region is immediately NH2-terminal to the leucine 
zipper, and mns to opposite sides of the DNA double helix as continuous extensions from the 
leucine zipper and is embedded in the DNA major groove over a 13 or 14 bp region (Fig. 2B). 
This region has a characteristic sequence rich in basic amino acid residues and mediates DNA 
binding through hydrogen bonds and hydrophobic interactions between amino acid side chains 
and bases in the major groove [15]. These direct interactions recognize five conserved amino 
acid residues in the signature sequence of the bZIP basic regions, namely NXXAAXXCR (X 
represents variable amino acid residue type) [18]. 
The DNA-binding region of zipper proteins was once thought to be a continuous alpha helix 
and to protrude from the DNA (Fig. 2A) [19]. However, doser examination of the amino acid 
sequences of Il proteins (Fig. 2A) showed that certain amino acids in the protrusion were 
conserved from molecule to molecule, suggesting that they aid binding and touch the DNA. 
Moreover, although the region was initially thought to be free of the helix-destabilizing 
residues (proline and glycine); asparagine, a more recently categorized potential helix breaker, 
was found to lie at a fixed point in the DNA-binding region of every protein. This would allow 
the protruding section to bend and thus contact the DNA continuously. 
It is not surprising that the composition of the a-helices in both regions of the bZIP domain 
differ. In the basic domain, the a-helix surfaces are designed to repel one another whereas in 
the zipper region, they form an amphiphathic phase in which hydrophobic amino acid residues 
are regularly spaced altemately three or four positions apart in the sequence. As a result of this 
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Fig.2 A) Sequence alignment of various bZIP transcription factors. 
Conserved amino acids in the basic regions and heptad repeats of the leucine 
zippers are highlighted in grey. B) BZIP transcription factor. Structure 
consists of three alpha helices. BZIP domain is at the Carboxyl terminus. 
Leucine zipper is formed by heptad repeats of leucine zippers (LLLMLL or 
LLLL YL). These leucines form the hydrophobie core of a coiled coil which 
extends away from the DNA in a directions perpendieular to the overall DNA 
helix axis. The basic region is immediately NH2-terminal to the leucine zipper is 
required for DNA binding through hydrogen bonds and hydrophobic 
interactions between amino acid si de chains and bases in the major groove. 
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characteristic spacing, the hydrophobic si de chains form a stripe down one si de of the alpha 
helix. The hydrophobic stripes make up the interacting surfaces between the alpha-helical 
monomers in a coiled-coil dimer [14]. 
The activation domain which lies at the NH2 terminus is rich in conserved acidic residues such 
as glutamic and aspartic acid, which confer its transactivation potential. This region may also 
be rich in proline, serine and threonine residues [15]. 
The first bZIP domain was discovered in 1988 as a he at-stable factor in rat liver nuclei that was 
capable of interacting with the CCAA T box motif present in several cellular gene promoters 
and certain viral enhancers. It was named CCAATlEnhancer Binding Protein (CIEBP-a.) [14]. 
An effort to find other proteins with sirnilarities to the CIEBP family yielded the discovery of 
two other bZIP subfamilies: the Activating Transcription Factor/CRE-binding protein 
(ATF/CREB) family and the Activating Protein 1 (API) superfamily (Fig. 3). These two 
subfamilies were defined according to their ability to recognize specific binding sites. The API 
superfamily controls gene expression by binding to TPA (12-0-tetradecanoylphorbol-13-
acetate) response elements (TRE) and is responsible for transcriptional induction of a number 
of genes in response to activation of protein kinase C (PKC) pathway [20]. The A TF/CREB 
family regulates the cyclic AMP (cAMP) response element (CRE) and mediates cAMP-
inducible genes in response to the activation of the PKA pathway [21]. 
2. API Superfamily. 
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Fig.3 BZIP Family subdivisions. The A TF/CREB family regulate the CRE while the API 
family control gene expression by binding to TRE. The CNC and MAF family are defined by 
unique conserved regions located NH2 terminal to their basic DNA binding domain, called the 
CNC domain and the EHR. The small MAF family members differ from the large MAF in that 
they do not contain a conical activation domain. 
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The API superfamily consists of a collection of structurally related transcription factors, which 
are further subdivided to either the JUNIFOS family or the CNC/MAF family 
(Fig. 3). 
2.1 JUN and FOS Families. 
The JUN (v-JUN, c-JUN, JUNB, JUND) and FOS (v-FOS, c-FOS, FOSB, FRAI, FRA2) 
subfamilies associate to form a variety of homo and heterodimers, aIl of which recognise TRE 
[20, 22, 23]. Like aIl other members of the bZIP family, the API farnily members must 
dimerize prior to binding DNA. Unlike the JUN proteins which can form very stable homo-
and heterodimers among themselves, the FOS proteins must heterodimerize with one of the 
JUN proteins since they can not form stable FOS-FOS homo- or heterodimers [24, 25]. On the 
basis of DNA sequence specificity and heterodimerization with JUN and FOS proteins, two 
other bZIP families of proteins have also been added to the API superfarnily (Fig. 3), the MAF 
and CNC families. 
2.2 MAF and CNC Families 
The MAF and CNC families are defined by unique conserved regions located NH2 terminal to 
their basic DNA binding domain called the extended homology region (EHR) and the 
Cap'n'Collar (CNC) domain, respectively [26, 27]. 
3. The MAF Family 
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The founding member of the MAF protein family (v-MAF) was originally discovered as the 
transduced transforming component of avian musculoi!poneurotic fibrosarcoma virus, AS42 
[27]. Since the discovery of v-MAF, several other MAF genes were identified, including its 
cellular counterpart c-MAF. In general, viral oncogenes are modified and sometimes truncated 
versions of their cellular counterparts, and they usually exhibit stronger transforming activities 
than do their cellular counterparts [28]. For instance, even under the control of a strong 
retroviral promoter, the c-REL proto-oncogene exhibits no transforming activity [29]. Sorne of 
the cellular oncogenes, su ch as c-JUN, exhibit sorne transforming potential when they are 
overexpressed, but mutations seem to be necessary to con vert them to fully transforming genes 
[30]. To this end, the overexpression of the c-MAF proto-oncogene was shown to cause cell 
transformation in chicken embryo fibroblast cells (CEF) [31]. 
Using a v-MAF specifie probe to screen a CEF cDNA library under relaxed hybridization 
conditions, the cDNAs coding two other members of the MAF family were isolated and named 
MafK and MafF [32]. Shortly after that, a third MAF, MafG, was identified using MafK as a 
probe to screen a chicken genomic library [33]. Early on these genes were noticed to share 
limited sequence similarity with the v-MAF gene. Also, their exon-intron structures were 
similar to each other but quite different from that of c-MAF. Furthermore, their putative gene 
products shared a high degree of structural similarity (65.4% identity), but they were only 
weakly related to the carboxyl terminus of the v-MAF protein [32]. During the same time, 
another MAF protein was identified as a retina specifie gene and named neural retina leucine 
zipper (NRL) [34]. In contrast to the MAFK, MAFF and MAFG, the amino acid sequence of 
the NRL gene product shared significant homology with c-MAF. When compared, the amino 
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terminal portions of the c-MAF and NRL were both rich in acidic amino acids, as is often the 
case in the transactivator domain of transcription factors. MAFK, MAFF and MAFG lacked 
this putative transactivator domain. These findings ultimately led to division of the MAF 
family into two separate subfamilies, the large MAF and small MAF families (Fig. 3). 
3.1 The Large MAF Family. 
The large MAF family encompasses c-MAF, NRL, MAFA and MAFB. Since their discovery, 
the large MAF family members were shown to play important roles in the differentiation and 
development of a variety of hematopoietic and neural tissue. For instance, c-MAF has been 
shown to play a crucial role in lymphopoiesis. By binding to the MAF Response Element 
(MARE) in the proximal interleukin 4 (lL4) promoter, c-MAF, which is induced and expressed 
in T helper cells 2 but not T helper 1 clones, upregulates the expression of the IL4 gene [35]. 
NRL, as mentioned earlier, is specifically expressed in retinal cells, including photoreceptors. 
In fact, its expression precedes that of rhodopsin during development [36]. Rhodopsin is the 
visual pigment of vertebrate rods, and its activation by light initiates the phototransduction 
process [37]. NRL has been shown to positively regulate the expression of Rhodopsin [38, 39]. 
MAFA, previously known as Lens-specifie MAF (L-MAF), has also been shown to be an 
important regulator in eye development. More specifie aIl y, MAFA has been identified as a 
factor that binds to and regulates the aCE2 sequence, which has been previously identified as a 
lens-specifie enhancer element in the chicken crystallin promoter [40,41]. The upregulation of 
crystallin gene transcription is an important marker for the differentiation of the ectoderm into 
lens cells [42]. Thus, vertebrate lens induction and differentiation can be triggered by the 
activation of MAFA [43]. MAFA most closely resembles MAFB (Fig. 4). MAFB has been 
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Fig.4 Large MAFs. Schematic representation of MAF A and other large Mafs. Acidic, basic, 
and leucine zipper (Lz) domains are indicated; H and G denote histidine and glycine repeat 
regions, respectively. Numbers in each domain indicate percent identity to MAFA. Amino acid 
positions are numbered (adapted from Ongino et al., Science, 1998). 
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identified as the affected gene in mice carrying the Kreisler (kr) mutation. The kr mutation was 
identified in an X-ray mutagenesis experiment, because mutant animaIs exhibited a hyperactive 
pattern of behaviour characterized by head-tossing and running in circ1es [44]. 
Kreis is the German word for circle and kr-I-:kr-I- animals are deaf and cannot SWlm, a 
constellation of findings characteristic of mutations that affect inner ear function. The inner ear 
function is abnormal due to a defect in hindbrain development. Pattern formation in the 
hindbrain is governed by a segmentation process that provides the basis for the organisation of 
cranial motor nerves. This process subdivides the embryonic hindbrain into eight subunits, 
termed rhombomeres (rI-r8) [45]. A cascade of transcription al activators, inc1uding the MAFB 
transcription factor, con troIs this segmentation process. 
In kreisler mutants, r5 fails to form and this correlates with abnormalities in the 
neuroanatomical organisation of the hindbrain. Two independent studies have been performed, 
using molecular markers, to monitor changes in the kreisler hindbrain. One concluded that r5 
and r6 are missing through a combination of changes in A-P identity and fate, followed by 
subsequent cell death [46]. The other study interpreted the data as the loss of overt 
segmentation of the hindbrain posterior to r4 leading to abnormal expression of markers in the 
region [47]. While the se reports c1early demonstrate that the posterior hindbrain in kreisler 
mutants has an abnormal organization, they do not address which processes (formation, 
maintenance, or the identity of segments) are affected. A more recent study illustrates that 
kreisler has roles in regulating multiple steps of hindbrain patterning. The complete absence of 
r5 in kreisler mutants shows that it has an early role in the specification of this segment. The 
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formation of r6 independent of r5 argues against a strict prorhombomeric model for 
segmentation of this region of the hindbrain in mouse. In addition, through the direct regulation 
of HOX genes, kreisler participates in the control of segmental identity. Ectopic expression of 
kreisler in r3 leads to its transformation toward an r5 identity [48]. Therefore, rather than being 
restricted to a single aspect of patteming, it appears to be an emerging therne that genes 
involved in controlling segmental processes in the hindbrain can act at several different levels. 
AdditionaIly, aIl three large MAFs, MAFA, MAFB and c-MAF were apable of specifically 
binding to and activating the insulin CI element within the nuclei of islet beta celIs, hence 
clearly playing a role in regulation of the insulin gene [49]. In summary, large MAFs play 
important roles in the differentiation, development and gene regulation of a variety of 
hematopoietic, neural and endocrine tissue [15,41,50]. 
3.2 The Small MAF Family 
The small MAF farnily consists of MAFK, MAFF and MAFG (Fig. SB). Typical of the bZIP 
family that the y belong to, the structure of the small MAF transcription factors is composed of 
a basic region rich in basic residues required for DNA binding and an adjacent leucine zipper 
region formed by a heptad repeat of hydrophobic residues, usually leucine, required for 
dimerization. The small MAFs differ in that they lack an obvious canonical activation domain 
[15]. As mentioned earlier, the distinguishing feature of the MAF transcription factors is the 
EHR domain, characterized by the presence of glycine and histidine clusters N-terminal to the 
basic domain (Fig. SA & SB) [41]. NMR spectroscopy provided an understanding of how the 
basic region recognizes the consensus sequence and also elucidated the mechanism of how the 
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EHR recognizes the flanking region. By drawing parallels to earlier findings that described 
how the SKNI transcription factor binds to the TRE [51], the amino acid sequence 
NXXY AXXCR within the MAFG basic domain was proposed to make direct interaction with 
the specific residues in the TRE, as weIl as with the phosphate backbone of the DNA. Using 
chemical shift perturbation experiments, two amino acids (Val 34 and Arg 35) in the EHR 
were shown to enable MAFG to make a broader area of contact and to recognize longer DNA 
sequences in the flanking region. This was further supported in another experiment where the 
truncation of the NH2-terminus was reported to result in loss of DNA-binding specificity. 
The first direct physiological role for the small MAF family emerged during the analysis of 
erythroid specific transcription, which has proven to be an excellent model system for 
deciphering the mechanisms goveming tissue specific and temporal aspects of gene regulation. 
MAFK was identified as one of the subunits of nuc1ear factor erythroid (NFE2) [52] and in this 
process, the small MAF family of transcription factors merged with the stream of molecular 
biology dealing with erythroid specific gene regulation. 
3.2.1 MAF Response Element (MARE) 
The NFE2 binding site was originally identified In the promoter of the porphobilinogen 
deaminase (PBGD) gene [53]. It has also been subsequently identified in the promoter regions 
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Fig.S The Small MAF family. A) The functional domains of the small MAF proteins. B) The 
amino acid sequence alignment of the murine MafF, MafG and MafK. Conserved leucine 
residues are shadowed in grey. Conserved amino acids are in grey. 
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of several erythroid specifie genes such as ferrochelatase [54] and 5-Aminolevulinate synthase 
(ALAS-E) [55] as weIl as in the Locus Control Region (LCR) of the Globin gene [56]. The 
NFE2 consensus binding site was determined to be [TGCTGACTCAC]. The core of its motif 
bore a striking resemblance to that of the TRE. Further investigation into the binding sites of 
MAF homodimers showed that they bound either a 13 bp palindromic sequence which had the 
TRE core or a 14 bp palindromic sequence with the CRE core. The former sequence was called 
TRE-type MAF Response Element (T-MARE) [TGCTGACTCAGCA]. The latter was called 
CRE-type MARE (C-MARE) [TGCTGACGTCAGCA] (Fig. 6). The specifie flanking regions 
[TGC] and [GCA] at either end of the core TRE/CRE were shown to be crucial for recognition 
of the MARE by MAF proteins [57] and are what distinguishes the MAF family proteins from 
members of the API or CREB/ATF family [13, 34, 57]. 
Using Surface Plasmon Resonance microarray studies, it was concluded that MAREs create a 
huge diversity in the regulation of gene expression through single base alterations. Such subtle 
changes in the MARE sequences are sufficient to alter rather drastically the binding specificity 
for any given transcription factor dimer and thereby impart enormous diversity to gene 
regulatory networks formed by the MAF/CNC families of transcription factors [58]. 
In effect, the resemblance between the NFE2 binding site and the T-MARE sequence was 
actually what provided the initial insight into the possible role that the small MAF proteins 
might be an essential subunit of transcription factor NFE2. The striking similarity between the 
MARE and the Antioxidant Response Element (ARE) sequence led researchers in a different 
direction. This crucial observation opened up the field to investigate the role of the small MAF 
heterodimers in the regulation of cytoprotective genes. These genes, su ch as, glutathione S-
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Fig.6 MAF Response Element (MARE). Consensus sequences recognized by 
bZIP transcription factors. TRE and CRE are included within T -MARE and C-
MARE, respectively, and establish the core sequence of the MARE (black). 
Three bases on each side of the core form the flanking sequence (in grey), 
which is critical for recognition of the MARE by Maf family proteins [50]. 
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transferase (GST), heme oxygenase-l (H01) and NAD(P)H:quinone oxidoreductase 1 (NQ01) 
[59], give cells the ability to adapt to oxidative stress or to xenobiotic exposure. It has long 
been known that the genes encoding the se enzymes are often coordinately regulated through 
AREs in their gene-regulatory regions [60,61]. 
3.2.2 Small MAF gene targeting. 
The role of the small MAF members in ARE-dependent gene regulation became apparent when 
MafG -f-:: MafK -f-:: MafF -f- fibroblasts lacking all three small MAF proteins were established 
and examined (Table 1). After exposure to l-chloro-2,4-dinitrobenzene (CDNB), which is 
known to act as a strong oxidative stress agent, a complete loss of mRNA induction was 
observed in almost al1 of the ARE- dependent genes examined, i.e. GST, NQ01, H01, 
glutamate-cysteine ligase catalytic subunit (GCLC) and thioredoxin reductase 1 gene 
(TXNRD1) [62]. Interestingly, when MafG-f-:: MafF-f- mice were examined none of the above 
tested genes, other than NQOl and TXNRD1, achieved any significant loss of induction. This 
implies that each single small MAF protein is more or less capable of supporting ARE-
mediated transcription al activation. This was the first report that genetically demonstrated the 
ability of each small MAF protein to con tribu te to ARE-dependent gene activation and the 
essential roles of the family of small MAF proteins in the activation [62]. Hence, functional 
redundancy has made it difficult to assign specifie in vivo roles to each of the small MAF 
transcription factors. In reality, prior to the triple knock-outs, null mutation of all three small 
MAF genes did not greatly clarify in vivo functions of this extensively interacting regulatory 
network. Those studies showed that MafK and MafF loss of function resulted in no discernable 
phenotype in homozygous mutant animaIs [63,64] (Table 1). MafG null mice were also viable, 
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but exhibited mildly impaired platelet formation, as weIl as behavioral abnormalities [65] 
(Table 1). The neurological abnormality was exacerbated in MalG -1-:: MafK -1- compound 
mutant mice, further supporting the argument that MAFG and MAFK share compensatory 
functions in the central nervous system [66]. Present findings showing that baroreceptor 
stimulation by phenylephrine can induce MAFG expression in cardiovascular control sites 
involved in the central processing of baroreceptor input, further supporting that MAFG may 
play critical functions in signal transduction in the central nervous system [67]. 
3.2.3 Small MAFs Tissue Distribution Analysis. 
ln order to shed light on the physiological functions of the small MAF members, the tissue 
distribution of their mRNAs in chicken, mice and humans were examined. In chickens, the 
levels of MafK transcripts were less variable among the tissues analysed and were relatively 
high in lung, mesentary and bursa of Fabricius. The MafF gene was found to be expressed in 
brain, heart, mesentary and ovary [32]. 
ln mice, the mRNA expression pattern of aIl three small MAF was compared usmg a 
quantitative fluorescence PCR assay. Not unexpectedly, each of the small MAF mRNAs 
displayed a unique expression pattern: although MafK and MafF were most abundantly 
expressed in the lung, MalG appeared to be most abundant in the heart. MalG transcripts 
differed by no more than lü-fold in any of the tissues examined, whereas MafF levels in 
different tissues varied by more than 65-fold [64]. Examination of MafK during murine 
development led to discovery of two different promoters. More specifically, murine MafK was 
shown to be composed of four exons. The two first two exons, lM and IN are independent of 
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Table 1. Small MAFs gene targeting phenotypes. 
MafK and MafF loss of function resulted in no discernable phenotype in homozygous mutant 
animaIs [63, 64]. MafG null mice were also viable, but exhibited mildly impaired platelet 
formation, as weIl as behavioral abnormalities [65]. The neurological abnormality was 
exacerbated in MafG -f-:: MafK -f- compound mutant mice [66]. The triple knock out die in 
midgestation [62J. 
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Knock Out Phenot),rpe 
MafF 
MafK 
MafG 
MafG/MafK 
MafG/MafF 
MafF/MafK 
MafG/MafF/MafK 
Normal 
Normal 
Decrease in Platelets, Mild motor disorder 
Platelets strongly reduced, Motor disorder 
earlier, Perinatallethality 
Compromised expression of a subset of 
ARE-dependent genes 
Fertile and Healthy 
Embryonic Lethality at midgestation 
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each other and encode two distinct 5' UTRs for expression in either the mesodermal or 
neuronal tissues, respectively. The second and the third exons which encode the entire protein 
coding sequence appear to be used in common by either MafK transcripts. [68]. In sirnilar 
fashion, the murine MafF locus is organized with two coding exons. However, it is regulated 
by three different promoters which, are alternatively spliced to generate three MafF mRNAs 
that encode the same protein product [64]. 
In human ce 11 s, MAFK and MAFG mRNA expression were examined by Northern blot 
analysis. The MAFK mRNA was abundantly expressed in heart, skeletal muscle and placenta, 
whereas MAFG mRNA was expressed at a high level in skeletal muscle and only moderately in 
heart and brain. The MAFF transcript was also observed in the placenta as we11 as term 
myometrium and kidney [69]. Large size transcripts of MAFK and MAFG were found in aIl 
tissues, which became apparent upon longer exposure of the Northern blot filters. In particular, 
the large size transcript of MAFK was quite strong in placenta [70]. These transcripts may 
reflect alternative RNA processing as seen in mice. 
4. The CNC Family 
Over the last several years, three groups of sma11 MAF interacting molecules, JUN, FOS and 
CNC families, which can form either productive or unproductive complexes, have been 
described [71]. The most physiologically important of these partner molecules are probably the 
vertebrate CNC transcription factors, so named originally for their sequence homology to the 
Drosophila Cap'n'Collar protein [72] (Fig. 7). The CNC domain spans 43 amino acids 
immediately amino terminaI to the basic domain and is highly conserved among the farnily 
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members. This family includes the Drosophila CNC, C. elegans SKNI and vertebrate p45, 
NRF1, NRF2, BACHI and BACH2 proteins. 
4.1 P45 
As mentioned earlier, this was the first identified partner molecule of MAFK. Together they 
forme the erythroid specific transactivator NFE2. NFE2 was purified from mouse 
erythroleukemia (MEL) cens as a novel bZIP transcription factor composed of a 45 kDa 
subunit (p45) and an 18 kDa subunit (MAFK) [52]. Surprisingly, p45 nun mutant mice 
exhibited normal erythropoiesis and instead showed high mortality due to severe hemorrhaging 
resulting from the absence of circulating platelets [73]. Further investigation indicated that 
proplatelet formation, a pathway of platelet production from megakaryocytes, was significantly 
inhibited in p45 null megakaryocytes [74]. 
4.2NRFI 
NRFI was isolated from a cDNA expression library using a probe containing the tandem 
MARE of the ~-globin LCR [75, 76]. It is strongly expressed in muscle, kidney, liver, lung, 
heart and ovary [75]. Nif] nun mice were found to die of anemia at late gestation [77]. 
However, embryonic stem (ES) cells with a disrupted Nif] were still able to contribute 
efficiently to blood formation in chimeric animaIs [77]. This unexpected result indicates that 
the defective erythropoiesis in Nif] nun mice is non-cell autonomous, i,e, the wild-type cells 
surrounding the mutant cen can rescue the mutant phenotype. To further exploit the availability 
of cens from Nif] nun mice, the involvement of NRFI in the regulation of antioxidant gene 
expression was also examined. Results indicated the NRFI plays a role in the 
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FIG.7 The CNC family. Alignment of human CNC proteins NRF3, NRFl, 
NRF2 and p45. Identical residues among proteins are in black. Conserved 
amino acids are shaded. 
- 51 -
lINIlFl 
hN lU"1. 
lIlf 111') 
hlfll'l 
liN Il''l 
bN l' 3 
hN lF 1 
JlNIIPl1 
liN .", 
bN Il'' 1 
hN It,:a 
bp' S 
hN RF) 
h. Il li' 1. 
htlR.' 
h.p f Sc 
liN RF3 
hN .Pl 
hN RF:.l: 
hp f Sc 
hN Il'3 
bN R' 1 
hN R,a 
bp .. S 
blllt,3 
JIN It F l 
liN Il''2 
bp • 5 
hlfllF3 
JIN RFl 
hlflll'2 
h:p45 
L P IlIT" QI) BL!'IPIGP"B L!lPIS" S GO. G R~OB .• , 0 a.p"" P P i 0°11 ~.G V l 00 
SQr. i'Fi-'-!!1 ... p ol]Q lfNt"~.Tr.l)!JTO~ U,...JfTPTAIt.1t SO XlII 92 
1" 0 
1 !il 2 
21 
•..•.•••••.••••• u~. 'l,V 0'." CI 'il'. 
• Q (1' Il L'Il,;""'. ,'OZ' 'If' 1I0IRI'f.oJ:~,J:U :,;0 LQK ! JI' ..~. • • • • • • • •• 1 OZ' 1: A 11: Il.· ••• •• •• •••••••••••• fi. p.. 2 li , 
A.I~PtlAQQ ...... CAIiIIII.O· ••• VLIt'X U:AIDH IUc/IU,lIal.V. ~ u 
PL.t 11 TOI.1' Il Q li Atnlou, ft III: IDA ~ 'uo!"C xo L~AQ"r p P\' J);~)I VI. 12 l 
1011: lUI· -. 'II. .;!iï. Cillai-Il + 1 OZ' "1 ... n ...... . i;;~;~ ~:â êà" ~,'~ :0' ;; ..... ;~j~;~ 
MPC:: OUIt IlIX. u~, .... 
, S . .. Q1o.f.l'. :S!.iLH ltAILL CPtUIt'!1I1Ut.DI'l'j,aISQsolt l'lLO 
/'.. >.)l, ~z..~a <tAS'I' I)I1.P8 - _ •. P.V~L VAIIJ' -. -. - -. --
K XE: .. " PB 1"'FBI)8PS.l;1 TUIPNO.----"--. ilp 2 AI' - - - - - • - - - • - • - - A l' Y G l'II' l' !iI- - - . - - -- -y C l' 
t.ltO· *1.'0 D :tIL'CI'I" tI ote.18 li A.' ..... If!S. ASI X l'SA .. ~.'.p~ Uy.,;.,:" A' W QJI~S L 
u?>u"t TJf! SI'- - ·U~:frl VI) , ug 
P,,~" . * ••••••••••••• - •• - •• - ••• _ ••• 
.~--...• ~S·IVI).KM~'_".L!$QDilYD 1)1.,.; .. 111_ 
-ST Il ppp O.HG'l'~nTAGPEL DI' G n &.1. E 
--1)1. PEnIl .. ~A! .. S~Uf- ----'Sll.P;~A~.; Bi slLfh~p 
PPPIBLPASlsBVP' PYSYGN-K"IPVS~LS S P~P 
QII 1 1)l:!F 
tBllOM K EST A p.": - • -AG PII:iI'Q 
:r: p ;- :: -j ',~ ~-i :: T 
t F. - r - -, - 1-; :. - 1 
F: .--,.~!J-J 
L~P, l~:~,l 
°IiK" ;XJ" NSIVCœ.~------ ----------AIIYC'l'DRE o JI"' ~,lS;$ BG SSraS5SSSSSASSSASS6FSBJ: AVOT 
m' .' 
Il' P 1)." E' VE TG LLO·--·------------------~~" ;'0, .,';:r-
J'KY S 
ZTV Z N--- ------ ------ ------ ------ ----- ------ ------
- - - - -. -IU •• 8_.;t>. 
~ ;;;;; ;j; ~ :i:;i!Ii;~ ... -_ .. -!.,' ItIOl.I'OI,'ltlil .. IITY_ .. , .. l''F8. ii; .. Slt 1I.1>01C8 01C%'8 .• n .• CT y uv RtlHTU" PSU OSA~1f SU'~;'" • - •• _. _ ••. -MOAl~p OSIUI*' QC" '1'1'~;J:L va... _. _. -... 'l'_glU n 
- ••• - - •••• - •• V~" r; A iJII .... - ....... - -... - . 
lI). 
l 11 
:1 18 
47 
3 9 l 
• 19 
:3 1) 0 
123 
.. 67 
5 19 
3 75 
17. 
SU 
5 \1 5 
.. Il:2 
:ln 
'"1'·11'" os: 0&"1 ~ $! l~fT 1.1"1 JI n ~ 1:  J;OcI • 3) '1 Il 'l.! ~' .. j r~ 1.. • _ .. l ~! \ H,: l,'j !~ ::... :' \r .': n ;.i ""î., t~ :. ,:. 'or .':' ?- ri ~ L i,_ ~, 1 1<: 1: F :: ~~J f. '.' t. h ! ... ' ~~ ~,' ~I~I ~ Y~V~~A~~W~ l-i. ~:' 1 !' }/ r.. :f::-J l~ '.' .... ~\ ':',;!~ ;" j.;; y, r.. K~l~~K Y~V~AAQ~~H 
SJf_ •. ·. uolilcJllil-. 59. 
- "'''l~CBRIF D~RIt 74:01 
"{-------"::_- 58' 
- •• -------- 113 
C'l 
\f'I 
regulation of Glutathione (GSH) synthesis VIa the expreSSIOn of its two subunits y-
glutamylcysteine synthetase (GCS) and glutathione synthetase (GSS) [78]. 
However, important new findings in adult hepatocytes obtained from chimeric NRFI deficient 
embryonic stem cells show that expression of these genes (GCS and GSS) were not affected. 
Loss of NRFI in these cells was associated with a significant increase in intraceIluIar ROS 
levels that was coupled with elevated lipid and DNA oxidation. Furthermore, chimeric mice 
generated with NRFl-deficient embryonic stem cells showed widespread apoptosis in fetal 
livers at late gestation, demonstrating a cell autonomous role of NRFI in the survival of 
hepatocytes. Although the basis of this discrepancy is not known, it may be attributed to that 
only a subset of ARE-dependent genes depends on NRFI in adult hepatocytes [79]. 
4.3 BACHI and BACH2 
BACHI and BACH2 were discovered by yeast two hybrid screening [80]. The BACH famiIy 
proteins harbor a protein-protein interaction domain (cal1ed a BTB domain, for broad complex 
tramtrack bric a brac, also known as a POZ domain, for pox and zinc finger) in addition to the 
characteristic CNC-type b-Zip structural elements. BACHI is a ubiquitous factor and is highly 
expressed in hematopoietic organs, such as the bone marrow and fetalliver [81], while BACH2 
is most abundant in the brain and B lymphocytes [80]. Similar to the small MAF family 
members, the BACH factors do not contain a canonical transcriptional activation domain and 
repress transcription when expressed transiently in fibroblasts. In fact, BACH2 has been shown 
to function as an inhibitory factor, which represses a set of genes during oxidative stress. In 
response to oxidative stress, BACH2 translocates into the nucleus, and by competing with 
NRF2 for MAF family partner proteins it targets certain ARE-dependent antioxidant genes 
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[82]. It has also more recently been shown, via its negative effects on proliferation and 
differentiation of neuronal cells, to serve as a gatekeeper of the differentiated status of the se 
cells [83]. 
BACH! has also been linked to oxidative stress and plays a pivotaI role in setting the levels of 
both constitutive and inducible expression of HO!, who se byproducts mediate anti-
inflammatory and anti-oxidant actions. Myocardial expression of HO! protein in Bachl-I -
mice was constitutively up-regulated when these mice were subjected to myocardial 
ischemia/reperfusion (IIR) injury in vivo. While myocardial IIR induced HO! protein in 
ischemic myocytes in both strains of mice, the extent of induction was significantly greater in 
Bachl-I - mice compared to Bachrl+ mice. Also, myocardial infarction was markedly reduced 
in size in Bachl- I - mice, further supporting BACHI as a key player in the mechanism 
controlling the activation level of the cytoprotective pro gram involving HOI [84]. 
BACH! and BACH2 also possess a BTB domain [80]. In addition to enabling heterodimer 
formation with MAFK through their respective zipper motifs, it was demonstrated that 
BACHI-MAFK heterodimers interact with each other through the BTB domain, generating a 
multimeric and multivalent DNA binding complex [81]. Through this ability to form 
multimers, BACHI is believed to mediate interactions between distant, multiple MAREs, and 
thus may serve as an architectural transcription factor. With the identification of BACH family 
proteins, it was revealed that small MAF proteins have a wider choice of partner molecules for 
binding to MARE. Through the choice of dimeric partner, small MAF members can switch 
transcriptional activity from repression to activation. 
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4.4NRF3 
The function of the mammalian CNC factors has been extensively studied, but only a small 
amount of information is available on NRF3, the most recently identified member [85]. NRF3 
transcripts are primarily expressed in the placenta and at lower levels in heart, brain, lung, 
pancreas and kidney [85]. It was hypothesized that gene targeting of the mouse Nif3 locus 
would indicate a role for NRF3 in the placenta, however Nrf3 nuIl mice develop normaIly and 
ex hi bit no obvious phenotypic differences when compared to wild-type animaIs [86]. To test 
whether Nif3 null mice are still capable of giving normal birth, knock-out females and males 
were bred and it was found that both sexes were fertile and that females were able to bear 
normal-sized litters. Thus, although Nrf3 is highly expressed in the placenta and testis, and at 
medium levels in the uterus, its function can be compensated by other CNC members in these 
tissues. It was previously proposed that NRF3, in conjunction with NRF2, may have a role in 
keratinocyte function [87], but no skin abnormalities were observed in Nif3 -1- animaIs. In fact, 
contrary to NRF2, NRF3 was found to negatively regulate ARE-mediated expression and 
antioxidant induction of NQOl [88]. The complexity of CNC transcription factors was 
revealed by finding that the absence of NRF3 does not appear to cause addition al lethality in 
compound Nif3/Nif2 and Nrf3/p45 deficient mice [86]. Furthermore, the first description of in 
situ hybridization of Nrf3 in chick embryo failed to indicate any role for this transcription 
factor in hindbrain HOX gene regulation. Instead, the surprising expression in mesodermal 
embryogenesis implies an earlier more specifie role for NRF3 in gene regulation [89]. 
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4.5 NRF2 
Similar to NRF3 knock-out mice, the NRF2 null mice developed normally and were fertile and 
initially yielded no obvious defective phenotype. Furthermore, the y were not anernic, again 
indicating that erythropoiesis was not significantly affected by loss of NRF2 [90, 91]. 
However, because NRF2 is most prominently expressed in detoxification organs, such as liver 
and kidney, and organs exposed to the extemal environment, such as skin and lung [92], it was 
chosen as a prime candidate with which to study the possible interaction of CNC members with 
the ARE. Those studies led to a new paradigm in the field of molecular toxicology. NRF2 was 
identified as a major player in the antioxidant response. Results indicated that the expression of 
a specific subset of antioxidant enzymes, known as the phase II enzymes, was remarkably 
induced in the liver and was markedly dirninished in Nrj2 null mice [91]. This initial 
recognition of the involvement of NRF2 in the antioxidant response sparked a substantial 
amount of research in this field. It was found that insufficient induction of cytoprotective 
enzymes brings about an increased susceptibility of cells to toxic xenobiotics including 
acetaminophen, butylated hydroxytoluene, and diesel exhaust [93-96]. In addition to this 
deficient induction profile, cancer chemoprevention mechanisms are also aboli shed in mice 
deficient in NRF2 [97]. Using in vivo analysis, a point mutation detected in the promoter 
region of the Nrj2 gene in C57Bl/6J mice attributed the susceptibility of a strain of mice to 
hyperoxia [98]. This study demonstrated that NRF2 is fundamental to the defense against 
reactive oxygen species (ROS) and implied that hyperoxia is linked to the NRF2 locus. Thus, 
protection against electrophiles and ROS share a common mechanism, with NRF2 functioning 
as the central mediator. 
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5. CNCIMAFF Networking 
The CNC and BACH famiIy of transcription factors require small MAF partners in order to 
bind to the MARE sequence. The advantage in this scheme of compuIsory heterodimeric 
interactions between the CNC and small MAF famiIy members is that subtle variations in 
DNA binding specificity or in trans-activation or trans-repression potential can be achieved 
through dimer formation of onIy a Iimited number of b-Zip transcription factor partners. In this 
regard, it shouId be noted again that the small MAFs do not possess any canonicaI 
transactivation domain [15], and hence function as bidirectionaI reguIators of transcription, i.e. 
repressors in their small MAF homodimers state and activators when in heterodimeric state 
with CNC family members. Thus, a deficiency in small MAFs would impair the function of 
CNC factors yet an excess of small MAFs is also predicted to increase small MAF homodimer 
formation and lead to repressed transcription. Indeed, it has been demonstrated that regulation 
from MARE sites can be tumed on and off in living cells by experimentally manipulating the 
balance between the small MAF proteins and partner molecules that contain trans-activation 
domains [99-101]. When these findings were extended into an animal model, embryos 
overexpressing transgene-derived-MAFK died of anaemia. AdditionaIly, it was discovered that 
megakaryocytes obtained from these mice exhibited reduced proplateIet formation and MARE-
dependent transcription, a simiIar phenotypes to MafG -null megakaryocytes. When the MafG 
null mutants were bred to MAFK overexpressing animaIs, both Ioss- and gain-of-function 
phenotypes were reversed. This resuIt provided direct in vivo evidence that the quantitative 
balance between the small MAFs and their heterodimeric partner molecules serves as a 
molecular switch for gene expression [102]. Nagai et al. went further to demonstrate that 
MAFK homodimers can suppress transcription, not only by competition for the DNA binding 
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site, but also by direct inhibition of transcription. Using domain analysis they showed that 
MAFK possesses a suppression domain in its basic region-leucine zipper [101]. 
More recent evidence provides yet another ex ample in which one of the small MAFs, MAFG, 
achieves repression not through simple passive repression but through sumoylation, which then 
mediates transcriptional repression through recruitment of a histone deacetylase containing 
complex [103]. This is particularly interesting when taken together with earlier findings that 
small MAF proteins co-Iocalize with heterochromatin prior to induction by DMSO, but co-
localize with p45 after induction [104]. Upon induction, relocation of small MAF proteins 
coincides with movement of the P-globin locus from heterochromatin to foci containing p45. 
Thus, one can speculate that the cue for differentiation is first bestowed upon small MAF 
proteins, which initially sequester the P-globin locus within heterochromatin. Subsequently, the 
small MAFs bring the P-globin locus to the p45 foci where genes are actively transcribed. 
These lines of evidence have introduced a new concept to the understanding of regulatory 
mechanisms directed by bZIP transcription factors. Small MAFs, as homodimers or as part of 
repreSSlve heterodimers, repress transcription by either passively competing with 
transcription al activators for the MARE or actively recruiting a repression complex. In 
addition, small MAFs act as transcription al repressors by sequestering gene loci within 
heterochromatin. Alteration in subnuclear localization has thus emerged as a potentially 
important mechanism in the regulatory system directed by small MAF and CNC proteins. 
- 58-
B. Oxidative Stress and the Female Reproductive System 
Although NRF2 may have sparked an enormous interest in oxidative stress and the 
mechanisms in which this process is controlled in the ceIl, the concept of oxidative damage is 
not a novel one. 
1. Oxidative stress 
Oxidative stress is imposed on cells as a result of one of three factors: 1) an increase in oxidant 
generation, 2) a decrease in antioxidant protection, or 3) a failure to repair oxidative damage. 
Cell damage is induced by free radical species which are unstable and highly reactive [105]. 
Free radicals are defined as any species with one or more unpaired electrons in the outer orbit. 
They become stable by acquiring electrons from nucleic acids, lipids, proteins, carbohydrates 
or any nearby molecule causing a cascade of chain reactions resulting in cellular damage and 
disease [106, 107](Fig. 8). The generation of the highly reactive free radicals is an inherent 
feature of normal cellular metabolism [108]. There are two major types of free radical species: 
reactive oxygen species (ROS) and reactive nitrogen species (NOS). NOS have been associated 
with asthma, septic shock and artherocIerosis. The two common examples are nitric oxide 
(NO) and nitrogen dioxide (N02). ROS on the other hand, are either reactive anions containing 
oxygen atoms or molecules containing oxygen atoms that can either produce free radicals or 
are chemically activated by them. Examples are hydroxyl radical (HO-), superoxide anions 
(02-), and hydrogen peroxide (H20 2). Most reactive oxygen species come from endogenous 
sources as byproducts of normal and essential metabolic reactions, such as en erg y generation 
from mitochondria or the detoxification reactions involving the liver cytochrome P-450 
enzyme 
- 59-
,,"---
Fig.8 Free radicals and Oxidative Stress. There are two major types of free 
radical species: reactive oxygen species (ROS) and reactive nitrogen species 
(NOS). Oxidants are generated as a result of normal intracellular metabolism in 
mitochondria and peroxisomes, as weIl as from a variety of cytosolic enzyme 
systems. In addition, a number of extemal agents can trigger ROS production. A 
sophisticated enzymatic and non-enzymatic antioxidant defence system 
inc1uding catalase (CA T), superoxide dismutase (SOD) and glutathione 
peroxidase (GPx) counteracts and regulates overall ROS levels to maintain 
physiological homeostasis [109]. 
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system. Exogenous sources include exposure to cigarette smoke, environmental pollutants su ch 
as emission from automobiles and industries, consumption of alcohol in excess, asbestos, 
exposure to ionizing radiation, and bacterial, fungal or viral infections. 
Under normal conditions, scavenging molecules known as antioxidants convert ROS to H20 to 
prevent overproduction of ROS. There are two types of antioxidants in the human body: non-
enzymatic antioxidants and enzymatic antioxidants. 
Non-enzymatic antioxidants are also known as synthetic antioxidants or dietary supplements 
e.g. vitarnin C, vitamin E, selenium, zinc, taurine, hypotaurine, glutathione, beta carotene, and 
carotene [110]. A good example of how one of these non-enzymatic antioxidants functions is 
vitamin C. Il is a chain breaking antioxidant that stops the propagation of the peroxidative 
process and also helps recycle oxidized vitarnin E and glutathione [111]. 
Enzymatic antioxidants are grouped into Phase 1 and Phase II enzymes. Phase 1 enzymes (e.g. 
cytochrome P-450, peroxidases, oxidases, lipoxygenases and hydroxylases) activate the 
harmful xenobiotics, drugs and carcinogens; while Phase II enzymes (e.g. NQOl, GST, 
superoxide dismutase (SOD), catalase, glutathione peroxidase and glutathione reductase) 
detoxify them [112]. These enzymes are constitutively expressed at a low level under 
physiological conditions. However, their expression is increased in ceIls exposed to a diverse 
range of compounds, including oxidants and electrophilic agents that can also undergo redox 
cycling to produce excess reactive oxygen species. Central to the induction of these enzymes is 
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the transcription factor NRF2, which acts through the ARE to activate gene transcription [113, 
114] 
1.1 NRF2 Regulation 
The involvement of NRF2 in both the constitutive and the inducible expression of ARE-
dependent genes has been weIl established and documented in numerous in vitro and in vivo 
studies [91, 95, 115-118]. This sparked a great interest in investigating the molecular 
mechanisms and signalling pathways that regulate the activation of NRF2. 
In comparing the human NRF2 and chicken ECH amino acid sequences, six highly conserved 
regions were found and named homology domains Nehl to Neh6 (NRF2-ECH homology) 
(Fig. 9A). The first conserved domain, Nehl, contains the CNC homology region and basic-
leucine zipper domain. The amino and carboxyl termini of the proteins are also highly 
conserved, and are referred to as Neh2 and Neh3, respectively. AdditionaIly, there are two 
conserved acidic domains (Neh4 and Neh5) as weIl as a serine-rich conserved region (Neh6). 
Elucidation of the relationship between the structural domains of NRF2 and their function 
showed that deletion of the N-terminal Neh2 domain enhances the transcriptional activity of 
NRF2 [119]. This suggested that the N-terminus is necessary for recruiting a negative regulator 
of NRF2. To identify the negative regulator of NRF2, GAL4 - Neh2 was used as bait in the 
yeast two-hybrid system. Inspection of the newly cloned cDNA revealed the presence of two 
canonical protein interaction motifs: a BTB domain [80] and a double glycine repeat (DGR) 
module [120] in the middle and at the carboxy-terminal end of the protein, respectively (Fig. 
9B). Database searches also revealed that this unusual combination of motifs is characteristic 
of the drosophila cytoskeleton binding protein, Kelch [121]; hence this 
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Fig.9. A) Functional domains identified in NRF2. Six functional Neh units 
were identified in NRF2. KEAPI interacts with the Neh2 domain and represses 
the activity of NRF2. Neh4 and Neh5 interact with CBP and synergistically 
contribute to the strong transcriptional activation exerted by NRF2. Nehl 
corresponds to the bZIP motif, mediating DNA binding and dimerization with 
small Maf proteins. B) Domain structure of KEAPI. KEAPI is divided into 3 
domains: BTB, NR (intervening region), double glycine repeat; also called 
Ke1ch domain. The DGRlKe1ch domain is important for NRF2 binding and 
interaction with the actin skeleton. The NR is important for KEAPI reactivity 
to electrophilic and oxidative stimuli. Two of the cysteine residues in the NR 
are crucial for the repressive activity of KEAPI on NRF2. The BTB domain is 
thought to be involved in dimer formation. 
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newly characterized protein was named Kelch-like ECH-associated protein 1 (KEAPl) [119]. 
It is agreed that KEAP1, acts by directly interacting with NRF2 and preventing its nuclear 
accumulation. However, the mechanism by which NRF2 translocates and accumulates in the 
nucleus is still in question. One model, "Static Model", proposes that NRF2 is retained in the 
cytoplasm by interaction with two molecules of KEAP1, which are dimerized through their 
BTB domains and anchored to the actin cytoskeleton via the Kelch or DGR region. Inducers of 
the phase II response interact with cysteine thiol groups in the intervening region (NR) of 
KEAP 1, causing the formation of disulfide bonds. This results in a conformation al change that 
renders KEAPI unable to bind to NRF2, which then translocates to the nucleus (Fig. lOB) 
[122]. The other model, "Cycling model", provides evidence to dispute the statie model and 
demonstrate that KEAPI does not passively sequester NRF2 in the cytoplasm but actively 
targets NRF2 for ubiquitination and de gradation by the proteosome under basal culture 
conditions. Several reports support this model in which NRF2 is degraded by the proteosome 
in a KEAPI-dependent manner [93, 114, 123] (Fig. lOA). It was demonstrated that KEAPI 
associates with Cullin 3 (CUL3), one of the components of ubiquitin ligase, to form a 
functional E3 ubiquitin ligase complex that targets multiple lysine residues located in the N-
terminal Neh2 domain of NRF2 for ubiquitin conjugation both in vivo and in vitro [124]. 
Inhibition of KEAPI-dependent ubiquitination of NRF2 correlates with decreased association 
of KEAPI with CUL3, not through the disruption of association between KEAPI and NRF2. 
This implies that the ability of KEAPI to assemble into a functional E3 ubiquitin ligase 
complex is the critical determinant that controls steady-state levels of NRF2 in response to 
oxidative stress. 
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1.2 CNCIMAF and Oxidative Stress 
NRF2 as weIl as the other molecules in the CNC family of transcription factors do not bind to 
ARE as homodimers or heterodimers [115]. Hence, it has been assumed that the involvement 
of CNC factors in ARE-mediated transcription obviates the involvement of the small MAF 
partners in order to bind to the ARE sequence. Indeed, data from several studies suggest that 
CNC/small MAF heterodimers are involved in the regulation of detoxifying enzyme genes and 
in the response to oxidative stress [91, 116, 117, 125-127]. Sorne studies report enhanced 
transcriptional activation when low amounts of small MAF proteins were cotransfected with 
the activating CNC factor [99, 116]. In aIl, however, increasing levels of small MAF inhibited 
both basal and CNC protein-inducible promoter activity, a result attributed by several to a 
putative shift towards MAF-MAF homodimer formation [99, 116, 128]. 
Although the ability of small MAF proteins to dimerize with CNC factors and bind to DNA-
recognition elements has been demonstrated by numerous researchers in various experimental 
systems in vitro, little information is available on the dimerization partners of the small MAF 
proteins in situ. Nevertheless, small MAFs play a role in the cellular response to hydrogen 
peroxide, heavy metals and electrophiles [129, 130]. For instance, increased expression of the 
hamster MAFG homologue (Adapt66) has been reported in HA-I hamster fibroblasts following 
exposure to H20 2 [131]. Furthermore, increase in all small MAF expression in HepG2 cells 
exposed to pyrrolidinedithiocarbamate (PDTC) and phenylethyl isothiocyanate (PEITC), two 
commonly used electrophilic agents, have been reported [130]. More recently, small MAF 
proteins have been shown to be involved in the cellular 
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Fig.l0 NRF2 Regulation A) Cycled model of NRF2 regulation. KEAPI 
associates with CUL3 and Rbx 1 to form a functional E3 ubiquitin ligase 
complex that targets multiple lysine residues located in the N-termÏnal Neh2 
domain of NRF2 for ubiquitin conjugation. B) Static mode) of NRF2 
regulation. NRF2 is retained in the cytoplasm by interaction with two 
molecules of KEAPI, which are dimerized through their BTB domains and 
anchored to the actin cytoskeleton via the DGR region. Inducers of the phase II 
response interact with cysteine thiol groups in the intervening region (NR) of 
KEAPI, causing the formation of disulfide bonds. This results in 
conformational change that renders KEAPI unable to bind to NRF2, which then 
translocates to the nucleus [122]. 
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stress response, based on the observations that heavy metals su ch as cadmium, ZInC and 
arsenite induce expression of small MAFs in human HeLa cells [129]. 
1.3 Oxidative Stress and Gestational Disorders 
Oxidative stress has been implicated in the etiology of multiple diseases that range from 
cardiovascular diseases su ch as atherosclerosis [132], to nervous system disorders such 
Parkinson's and Alzheimer's [133], to inflammatory-immune injury su ch as rheumatoid 
arthritis [134] and several kinds of gestational disorders [135]. As more research is done 
focusing on the reactive oxygen species in human diseases, there is new Iight being shed on the 
role of these radicals in the physiologie al functions of the female reproductive tract. There is an 
increased interest to examine the role of oxidative stress in female reproduction, because it may 
be a major Iink in the infertility puzzle as well as in sorne reproductive organ diseases. Oxygen 
radicals and reactive oxygen species are a double edged sword, because they play a dual role in 
the female reproductive tract. On one hand, the y can affect the physiologie processes involved 
in implantation to oocyte maturation to fertilization to blastocyst development [136-138]. On 
the other hand, they are capable of causing abortions [139], preeclampsia [140], free radical-
induced birth defects [141], and preterm labour [142]. 
Preeclampsia is associated with serious health complications for the mother and severe fetal 
morbidity and fetal mortality. Overall preeclampsia complicates 5% of all pregnancies and 
Il % of all first pregnancies. Preterm birth is defined as birth that occurs before 37 weeks of 
gestation. Preterm labour occurs in 5 to 10 percent of all pregnancies and accounts for 75 
percent of neonatal mortality and morbidity, including long-term handicap. The cost of caring 
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for preterm babies in the United States has been estimated at around $8 billion annually [143], 
which offers yet another reason why it is vital that research in this area uncovers the molecular 
mechanisms involved in the birth process, and to use that information to develop better 
diagnostic indicators and improve methods of therapeutic management. 
These gestational disorders can also be caused by extemal environmental agents that induce 
oxidative stress in the placenta. Perhaps one of the most notorious of these contaminants is 
arsenic. Arsenic has become a major public health concem worldwide because millions of 
people are at risk of drinking water contaminated with arsenic [144]. 
Arsenic has been shown to cross the placenta in both animaIs and humans. Experimental 
studies support a role for arsenic as a developmental toxicant leading to spontaneous abortions, 
birth defects and embryonic lethality [145-147]. Placentallevels of arsenic can be significantly 
increased in humans living in regions with high environmental contamination [148]. These data 
support the notion that placental cells are exposed to extensive oxidative stress during 
pregnancy, implicating oxidative stress in the pathogenesis of preeclampsia and miscarriage 
[149]. 
As mentioned earlier, arsenic has been already established to induce oxidative stress [150, 151] 
and NRF2 is a key player in the cellular oxidative stress response [152]. One conventional 
view predicts that the interaction of KEAP 1 with electrophilic or oxidant inducers through its 
thiol groups triggers the dissociation of NRF2 from the NRF2 lKEAPl/CUL3 complex in the 
cytoplasm, thus keeping NRF2 from ubiquitination by KEAPl/CUL3. Altematively, 
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oxidative/electrophilic signaIs inhibit the ubiquitination activity of KEAPI/CUL3, but not the 
association of KEAPI with NRF2, thereby allowing newly-synthesized NRF2 to bypass 
KEAPlICUL3 and accumulate in the nucleus [153]. 
2. Reproductive Organs 
The two major organs affected by oxidative stress in the female reproductive system are the 
myometrium and the placenta (Fig. Il) 
2.1 Myometrium 
The myometrium is the outermost part of the uterus. This smooth muscle organ consists of 
bundles of myometrial cells embedded in a matrix of collagen. Human myometrial cells have a 
complex cytoskeletal structure that is necessary not only for generating force within each cell, 
but also for transmitting contractile forces through a linkage of groups of cells and 
coordinating information to the connective tissue collagen fibers[154]. 
Myometrial contractions occur when phosphorylated myosin interacts with actin to form 
actomyosin. The subsequent hydrolysis of the phosphorylated protein-protein complex 
provides the energy for contraction. At the time of labor, the myometrium becomes excitable, 
spontaneously active and develops high frequency, high-amplitude contractions. The transition 
from a quiescent to active state has been termed activationafter which the myometrium can 
undergo stimulation in response to endogenous and/or exogenous agonists [155]. 
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Fig.ll Gestational Tissue. The myometrium is the outer most area of the uterus, comprised 
of smooth muscle that undergoe contractions during labor. The placenta is formed by two 
components the maternaI wall of the uterus (decidua) and the (tropoblast) cells from the fetus. 
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Prior to myometrial contractions, the fetus is almost entirely dependent on the mother. At a 
functionallevel, the mother must integrate maternaI and fetal physiology, immune system, and 
endocrine systems, a very delicate and vital task executed by the placenta. 
2.2 Placenta 
The human placenta lS a umque, transient organ, and possesses, through its capacity to 
proliferate and to invade maternaI tissues, qualities that are usually found in malignant tumors. 
However, growth and invasion at the fetal-maternal interface is under tight control and 
malignant placental tu mors are rare [156]. What is known is that profuse and steady maternaI 
blood flow to the placenta is clearly required to support fetal growth during the second and 
third trimesters. What is observed, however, is that the transition in the maternaI placental 
circulation at 10 to 12 weeks is a potentially dangerous one [157]. Without sufficient changes 
in the uterine vasculature in early pregnancy, the placenta is susceptible to the development of 
focal regions of hypoxia. Hence, careful orchestration is required to prevent overwhelming 
oxidative stress to the placenta, which may contribute to pregnancy failure. 
Plugging/unplugging of the spiral arteries appears to be related to successful invasion of the 
extravillous trophoblast cells. This process involves the penetration of the arterial walls and 
replacing part of the maternal endothelium such that the smooth muscle is lost and the artery 
dilates. In normal pregnancies trophoblast invasion is complete, unplugging of the vessels is 
orderly, and the arteries are fully converted (Fig. 12A). If trophoblast invasion is less complete, 
the vessels may retain sorne of their vasoreactivity and the unplugging of the vessels may be 
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Fig.12 Trophoblast Invasion of Maternai Decidua (Placentation) 
A) Normal placentation at IS to 16 weeks of pregnancy. During normal 
placentation, cytotrophoblasts cross these piacentai-maternal bridges and invade 
the maternaI decidua and adjacent spiral arteries. They penetrate the walls of the 
arteries and replace part of the maternaI endothelium, stimulating remodeling of 
the arterial wall such that the smooth muscle is lost and the artery dilates. 
During normal pregnancy, these immune cells facilitate deep invasion of 
cytotrophoblasts into the myometrial segments and promote extensive spiral 
artery remodelling. B) Poor placentation at IS to 16 weeks of pregnancy. In 
the preclinical stage of preeclampsia, invasion is restricted with impaired 
arterial remodelling [158]. 
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premature and disorganised (Fig. 12B), leading to a greater degree of intermittent perfusion of 
the intervillous space and placental oxidative stress, thereby predisposing the mother to 
preeclampsia or pregnancy failure [159]. In turn, reduced oxygen tension in the placental tissue 
may lead to the production and secretion of cytotoxic factors that have been postulated to affect 
the maternaI vasculature [160]. Indeed, it has been reported that the normal human placenta 
can produce more inflammatory cytokines, when incubated under low oxygen tension [161]. 
Proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-lb (ILIB) can 
produce endothelial dysfunction [162], and synthe sis of these cytokines as weIl as IL6 has been 
documented in the human placenta [163, 164]. Proinflammatory cytokines are notorious for 
affecting the endothelium in a fashion similar to events reported in preeclamptic women [162], 
and TNF levels are higher in the circulation ofwomen with preeclampsia [165]. 
There are increasing amounts of evidence suggesting an important role for the 
proinflammatory cytokines ILIB, IL6 and TNF in the events that lead to preterm labor, 
causing morbidity and mortality of the fetus and serious health complications for the mother 
[166, 167]. Furthermore, it has been reported that expression of the oxytocin receptor is 
regulated by ILIB, IL6 and TNF in uterine smooth muscle cells [167-169]. Hence, there 
appears to be a link between the presence of proinflammatory cytokines in the uterus or 
amnion and the induction of labor. 
3. Cytokines 
Cytokines are small, non structural proteins with molecular weights ranging from 8 to 40,000 
daltons. Originally called lymphokines and monokines to indicate their cellular sources, it 
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became clear that the tenn "cytokine" is the best description, because nearly all nucleated cells 
are capable of synthesizing the se proteins and, in tum, of responding to them. The concept that 
sorne cytokines function primarily to induce inflammation, while others suppress inflammation 
is fundamental to cytokine biology and also to clinical medicine. The concept is based on the 
genes coding for the synthesis of small mediator molecules that are up-regulated during 
inflammation. An example of genes that are proinflammatory are phospholipase A2, 
prostaglandin-endoperoxide synthase 2 (PTGS2, previously known as COX2), and inducible 
NO synthase. These genes encode for enzymes that increase the synthesis of platelet-activating 
factor and leukotrienes, prostanoids, and NO. 
While these genes may be essential to warding off the harmful effects of infection, they can 
also result in injury to the ho st from an over-exuberant inflammatory response that may exceed 
the damage caused by the inflicting agent itself. Examples of this phenomenon of self-in jury 
include sep tic shock, inflammatory bowel disease, and certain autoimmune diseases such as 
rheumatoid arthritis [170, 171]. Proinflammatory cytokines include cytokines su ch as TNF, 
ILIB and IL6. 
3.1IL6 
IL6 is secreted by T cells and macrophages to stimulate immune response to trauma, especially 
bums or other tissue damage leading to inflammation. It is one of the most important mediators 
of fever and of the acute phase response and is elevated in response to muscle contraction 
[172). 
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IL6 signaIs through a specifie interleukin-6 receptor (IL6R). In view of the fact that the IL6R 
lacks a tyrosine kinase domain, it requires an accessory signal transducer named gp130 [173]. 
There are two possible mechanisms of interaction of IL6 with its receptor. Cells with the IL6R 
may bind IL6 directly inducing homodimerization of gp130 leading to signal transduction. 
Altematively, the outer domain of the IL6R may be shed after proteolytic cleavage by protein 
kinase C to form soluble IL6R, which may also bind IL6. The formed complex can then cause 
homodimerization of gp 130 and initiate the signal transduction cascade by the tyrosine-specifie 
phosphorylation and subsequent activation of Janus kinases (JAKs) and Signal Transducers 
and Activators of Transcription (STATs) [174, 175]. 
3.2 TNF 
Another proinflammatory cytokine involved in labour, TNF, transduces growth regulatory 
signaIs into the cell through the TNF receptor (TNFR). TNF stimulates proliferation in normal 
cells; however, it initiates programmed cell death (PCD) or apoptosis in transformed cells 
causing DNA fragmentation and cytolysis [176, 177]. 
Upon ligation of TNF, the TNFR trimerizes and induces the association of the death domains 
(DD)s. Through functional studies the DD was identified as a conserved protein-protein 
interaction motif that is necessary for transmission of the apoptotic signal [178]. This 
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Fig.13 TNF Signalling. Once bound, TNF trimerizes the TNFR and induces the association of 
their DD. This aggregation recruits the adapter protein TRADD which in tum promotes the 
recruitment of the DD-containing cytoplasmic proteins FADD, TRAF2 and RIP to form an 
active TNF RI signaling complex. 
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aggregation of the DDs of TNFR recruits the adapter protein TNFR associated death domain 
(TRADD) [179], which in tum promotes the recruitment of DD-containing cytoplasmic 
proteins FAS-associated death domain (FADD), TNFR associated factor 2 (TRAF2) and 
receptor interactive protein (RIP) to form an active TNFR signaling complex (Fig. 13) [180]. 
The TNF-induced survival pathway is mediated by the transcription factor NFKB. Activation 
of NFKB occurs via phosphorylation of IKB at Ser32 and Ser36, resulting in the dissociation and 
subsequent nuclear localization of active NFKB. Recent studies have demonstrated that cells in 
which the NFKB signaling pathway is blocked are more likely to undergo apoptosis in response 
to TNF [181]. Therefore, the availability of NFKB may play a critical role in the ability of TNF 
to act as an apoptosis-inducer and anti-tumor agent. 
3.3ILIB 
A third inflammatory cytokine involved in labour is ILIB. ILIB signaIs primarily through the 
type 1 ILl receptor (ILIRl). ILlRl binds ILlB, but requires the ILlB receptor accessory 
protein (ILlRAcP) to transduce a signal (Fig. 14) [182]. ILlB binding causes activation of two 
kinases, IRAK-I and IRAK-2, associated with the ILlRl complex. IRAK-l (ILl Receptor 
Associated Kinase) activates and recruits TRAF6 to the ILlRl complex. TRAF6 activates two 
pathways, one Ieading to NF-kB activation and another leading to c-JUN activation. The TRAF 
associated protein ECSIT Ieads to c-JUN activation through the Map kinase/JNK signaling 
system. TRAF6 also signaIs through the T AB liT AKI kinases to trigger the degradation of 
IKB, and activation ofNFKB. 
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Fig.14 ILIB signal transduction through ILIRI. ILIRI binds ILIB utilizing 
ILIRAcP. ILIB binding causes activation of two kinases, IRAK-I and IRAK-2, 
associated with the ILIRI complex. IRAK-I activates and recruits TRAF6 to 
the ILIRI complex. TRAF6 activates two pathways, one leading to NF-kB 
activation and another leading to cJUN activation. The TRAF associated protein 
ECSIT leads to c-Jun activation through the Map kinase/JNK signaling system. 
TRAF6 also signaIs through the TABlffAKl kinases to trigger the degradation 
of IKB, and activation of NFKB. 
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From the above descriptions of ILIB signal transduction, it can be seen that many of these 
pathways are shared with TNF. Although the receptors for TNF and ILIB are c1early different, 
the postreceptor events are amazingly similar. Thus, the finding that ILIB and TNF activate 
the same portfolio of genes is not surprising. However, given the same cell and given the same 
array of activated genes, ILIB does not result in programmed cell death, whereas TNF does. 
Furthermore unlike ILIB, the receptors for TNF are homodimers and trimers, and, hence, the 
recruitment of kinases is somewhat different. 
The involvement of proinflammatory cytokines in the placenta and gestational membranes has 
been extensively investigated in the context of both normal and abnormal pregnancy and 
delivery. Patterns of expression of proinflammatory cytokines in the fetal membranes and 
decidua suggest that inflammatory activation occurs modestly with term labour, but much more 
robustly in preterm delivery, particularly in the presence of intrauterine infection [183]. 
The mechanism by which infection and/or inflammation may lead to labor are postulated to 
involve infection-induced release of proinflammatory cytokines, which in turn may stimulate 
prostaglandin synthesis by gestation al tissues, thereby causing uterine contractions [184]. 
Therefore, anti-cytokine therapy which has already emerged as an effective treatment in 
several human diseases such as arthritis, cancer and asthma, may prove a useful tool for the 
prevention of gestational disorders caused by infectious and inflammatory responses. 
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Specifie Research Aims 
The objective of this research was to investigate the involvement of the CNC family members, 
NRF2 and NRF3, and the small MAFs in arsenic or proinflammatory cytokines mediated stress 
in gestational organs, the placenta and myometrium. We explored if NRF2 may be involved in 
the antioxidant response to arsenic mediated stress in placental cells. Subsequent experiments 
investigated the DNA binding of endogenous NRF2/Small MAF heterodimers and one of the 
downstream target genes of NRF2. 
In light of data also suggesting an involvement of NRF3 and MAFF in placental function we 
examined if they might be expressed in a specifie subset of differentiated cells in placenta villi 
and also if their transcript levels are regulated during different periods of gestation. These 
findings prompted further experiments aimed at characterising the activation domain of these 
transcription factors. 
Due to the increasing literature on proinflammatory cytokine participation In gestational 
disorders we also examined the regulation of NRF3 and MAFF in placental and myometrial 
cells. 
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Chapter II 
MATERIALS AND METHODS 
1. Cell Culture and Reagents. 
1.1 Primary Cells and Cell Lines 
Primary myometrial cells were cultured in RPMI 1640 with 10% FBS. Human embryonic 
kidney 293T (HEK293T) cells were cultured in minimal essentiai medium alpha (MEM-a) and 
10% bovine growth serum. The human choriocarcinoma JAR cellline (American Type Culture 
Collection, Manassas, VA, U.S.A.) was maintained in RPMI-1640 medium plus 1 mM sodium 
pyruvate, 10 mM HEPES and 10% fetai bovine serum. The human choriocarcinoma cell Iines 
BeWo was maintained in F12K medium 10% heat-inactivated fetai bovine serum. The PHMl-
31 myometrial cells were maintained in high-glucose DMEM containing 0.1 mg/ml Geneticin, 
10% fetal bovine serum, 2 mM L-glutarnine. AIl media contained L-glutamine and were 
supplemented with 50 U/ml penicillin and 50 !-tg/ml streptomycin. 
1.2 Preparation of primary myometrial cells 
Primary myometrial cells were derived from 1O-30g of myometrium disseeted from a patient 
after a caesarian delivery. Prior institutionai approval for the protocoi was obtained. Procedure 
was adapted from bovine protocol cited in [185]. The tissue was placed in a 50 ml falcon tube, 
rinsed with IxHBSS (136.9 mM NaCI, 5.4 mM KCI, 0.3 mM Na2HP04, 0.4 mM KH2P04, 5.5 
mM Dextrose, 5.0 mM HEPES, pH adjusted to 7.3) plus 10,000 units penicillinlstreptomycin 
and eut into smaller pieces. The sample was then rinsed with 1 xHBSSlPenStrep four times and 
subsequently a filter sterilized enzyme mix (0.17 mg/ml Trypsin, 0.425 mg/ml Collagenase II, 
0.105 mg/ml Dnase II) was added to the sample in a 50 ml falcon tube. The tissue and enzyme 
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mix was then incubated for lhr at 37°C in 95% air with 5% CO2• 10 ml of FBS were then 
added to terminate the enzymatic reaction and the tissue was filtered through sterile gauze. The 
eluate was centrifuged at 1500g for 12 minutes. The pellet was washed 3 times with 
IxHBSSlPenStrep and plated into 6 weIl plates. 
1.3 Derivation of PHMI-31 cells 
PHM 1-31 myometrial cells were derived from the immortalization mixture used to derive 
PHMI-41 cells [186]. Briefly, myometrium was removed from the upper edge of the uterine 
segment at the time of caesarian section in a term pregnant patient who was not in labor, using 
a protocol that had received prior institutional approval (University of Texas Health Sciences 
Centre in Houston). Myometrial cells were isolated by enzymatic digestion, infected at passage 
2 with replication-defective adenovirus vector pLXSN16E6E7 (J.K. McDougal, University of 
Washington, Seattle, WA) expressing the E61E7 proteins of human papilloma virus 16 and the 
neomycin resistance gene and selected with the neomycin analog Geneticin (Invitrogen) [186]. 
PHM 1-31 cells were recovered by subcloning foci and reach confluency 3-4 days after being 
cultured at 2x105 cells/lOOmm dish and have been used in this study up to passage 25. The 
cells maintain smooth muscle u-Actin expression at passage 27 and retain the ability to 
respond to oxytocin and thapsigargin with an increase in intracellular calcium. 
1.4 Isolation of Chorionic Villi 
Informed consent was obtained from aIl patients. Placentas from elective terminations of 
normal pregnancies (12 to 22 weeks) or from normal term deliveries (34 to 40 weeks) were 
collected immediately after delivery, washed thoroughly in phosphate-buffered saline (PBS) 
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with antibiotics, and placed on ice. Chorionic villi were dissected free from the rest of the 
placenta and lysed immediately in TRIzol (Invitrogen). 
1.5 Isolation of Cytotrophoblasts and Placental fibroblasts 
Cytotrophoblast progenitors were isolated from pooled first- or second-trimester human 
placentas by published methods [187, 188]. Briefly, placentas were subjected to a series of 
enzymatic digests, which detached cytotrophoblast progenitors from the stromal cores of the 
chorionic villi. Once detached, the cells were purified over a Percoll gradient (Collaborative 
Biomedical Products, Bedford, MA). Cytotrophoblast cell islands, visualized by using a 
dissecting microscope, were dissected from the surface of early gestation placentas [189]. 
Fibroblasts were isolated from first trimester placentas and passaged as previously described 
[188]. The lines were used after the third passage to ensure that contaminating cells were no 
longer present. 
1.6 Induction studies 
PHMI-31 cells reaching 80-90% confluency were FBS starved for 16 to 24 hours. They were 
then treated with TNF (100 ng/ml, Medicorp), ILIB (0.005 to 100 ng/ml, Research 
Diagnostics) or IL6 (100 ng/ml, RDI) or combinations of these cytokines. Induction time was 
as indicated in the figures. For the inhibition experiments the cells were starved for 16 to 24 
hours and th en actinomycin D (5 !!g/ml) dissolved in DMSO (0.5%) or DMSO alone (0.5%) 
was added to the cells 1 hour prior to beginning the 3 hours treatment with ILIB (l ng/ml). The 
analysis of primary myometrial cells was carried out in the presence of FBS. JAR cells at 70-
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90% confluency were incubated with various concentrations of arsenic trioxide (AS203) 
(Sigma) or TNF for the times indicated. 
2. Plasmid constructs 
2.1 Expression Vectors 
AlI cDNA fragments were recovered by RT -PCR using their respective oligonuc1eotides. 
NRFl: hNRFI-Fnew (5'-GGTCCTTCAGCAATGCTTTCTCTG-3'), hNRFI-Rnew 
(5' -CCCTTCTTCCCCAGGCTCACTTT-3'), NRF2: hNrf2-Fnew 
(5'-CCCAGCAGGACATGGATTTGAT-3') and hNrf2-Rnew 
5'-GGTCAAATCCTCCTAAATCTAG-3'). NRF3: Full-iength NRF3 (694 amino acids): 
hNRF3-Fnew (5'-GCGATGAAGCACCTGAAGCGGT-3') and NRF3-Rnew 
(5'-CTCACTTTCTCTTTCCCTTTTGGG-3'). NRF3 (607 amino acids): NRF3-F607 (5'-
GCCATGGAGGGCCAGCTGCTCCGGGAG-3') and NRF3-Rnew 
(5' -CTCACTTTCTCTTTCCCTTTTGGG-3'). NRF3 (525 amino acids): NRF3-MT2Fl 
(5-CGCGAATTCGCCATGGAGAAGGCACCCGCGGAACCG-3') and NRF3-GSTRI (5'-
CACGAATTCTCACTTTCTCTTTCCCTTTTG-3 '). NFE2: The pMT2 NF-E2 expression 
plasmid has been described previously [190]. MAFF: MAFF-F2 
(5'-GGGCACCTTCTGCAAACATGT-3') and MAFF-R2 
5'-GAGGCGGCGCTCAGGCACTTT-3'). MAFK: hMAFK-FI (5'-
CGTGCCCGGGTTATGACGACT-3') and hMAFK-Rl (5'-
GGCCGGCACTAGGATGCAGC-3'). MAFG: The fulliength MAFG pMT2 expression 
plasmid has been described previously [190]. MAFG (407 bp) cDNA fragment with the 
primers MAFG611F (5'-CCGATCGTAGGGACGCGCGT-3') and MAFGI018R (5'-
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CCACTCGGGAGTGGAGGGAA-3'). PTGS2: COX-2 FI (5'-
CTGCCCGCCGCTGCGATGCT-3') and COX-2 RI (5'- CTACAGTTCAGTCGAACGTTC-3'). 
AIl resulting amplicons were cloned into pCR-BluntII-TOPO vector (lnvitrogen). 
Subsequently, aIl cDNA inserts with the exception of NRF2 and the NRF3, were digested with 
EcoRI and subcloned into the pMT2 expression vector. As the NRF2 and NRF3 cDNA 
fragments comprise internaI EcoRI sites, the inserts were recovered from the pCR-BluntII-
TOPO plasmid by a partial EcoRI digest before being subcloned into the EcoRI site of the 
pMT2 expression vector. 
2.2 NRF3 promoter Constructs. 
To map the NRF3 transactivation domain, we used PCR generated fragments using 
oligonucleotides with BarnHI restriction sites, to clone full-Iength (694 arnino acids) and 
shorter versions of human NRF3 into the BarnHI site of plasmid pSG424 in frame with the 
GAL4 DNA-binding domain [191]. For the pSG-NRF31-297 construct we used the EcoRI site 
present in the NRF3 cDNA to clone the fragment into the EcoRI site of pSG424. The (GaI4)s-
TKlluciferase reporter construct (a kind gift from Dr. Rongtuan Lin) was generated by 
inserting a 140 bp HindIIIIXbaI fragment from the (GaI4)s-TKlCAT vector [192] treated with 
Klenow enzyme cloned into the Smal site of the TKlpGL3 vector. As a transfection control we 
used the pRL-TK vector (Promega). Transient transfections of HEK293T ceIls for reporter 
assays were performed in 24 weIl plates using the calcium-phosphate co-precipitation 
procedure [193]. 104 HEK293T cells were plated per well and transfected with 100 ng of 
(GaI4)s-TKIluciferase reporter, 5 ng of pRL-TK and 500ng of either of the various pSG-NRF3 
constructs. 
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3. Transfections 
Transient transfections of HEK293T cells were performed usmg the calcium-phosphate 
co-precipitation procedure [193]. HEK293T cells at 30-50% confluency (lOOmm dish) with 
lO/lg of the expression plasmids. In the case of the fuII-length NRF3 (694 amino acids) 
expression vector we used 30/lg of the plasmid. Where mentioned transfection using Fu Gene 6 
reagent (Roche) was performed according to manufacturer' s specifications. 
4. Immunoblot analysis 
4.1 Protein Extraction. 
To prepare whole cell extracts (WCE): the cells were scraped using IxPBS, centrifuged and the 
pellets were then resuspended in NB buffer (250 mM sucrose, 420 mM NaCl, 10 mM 
TrisIHCl, 2 mM MgCIz, 1 mM CaCIz, 1 % Triton X-100) and protease inhibitors (0.5 mM 
dithiothreitol, 0.2 mM PMSF, IX protease inhibitor cocktail ("Complete", Roche). After 
incubation on ice for 10 minutes, samples were briefly centrifuged and the supematant was 
collected. Cytoplasmic extracts were generated using the same procedure as for WCE except 
that NaCl in buffer was omitted. Nuclear extracts were prepared by resuspending the pellet 
from the cytoplasmic extract preparation in NB buffer with 420 mM NaCl, centrifuging and 
collecting the supematant. The protein concentrations were determined using a protein as say 
kit (BioRad, Hercules, CA). 
4.2 Western Analysis 
20-30/lg of the lysates were electrophoresed in 4-12% NuPage Novex Bis-Tris (Invitrogen) or 
10-12% SDS-polyacrylamide gels. Resolved proteins were transferred electrophoretically to 
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PVDF membranes (Millipore). After transfer, the membrane was blocked for 1 hour at room 
temperature (RT) or ovemight at 4°C in IX Tris-buffered saline (TBS, 25 mM Tris-base pH 
7.5, 150 mM NaCI) plus 5% milk and was subsequently incubated ovemight with polyclonal 
sera in IX TBS plus 5% milk, 0.05% Tween-20 and 350 mM NaCl. Following washing of the 
primary antisera, the membrane was incubated for 1 hour at RT with secondary goat anti-rabbit 
or anti-mouse antibodies conjugated to horseradish peroxidase (Pierce). The proteins were 
detected using the Super-Signal West Pico chemiluminescent reagent (Pierce) following the 
manufacturer' s instructions. For competition experiments, the peptide antigen was added to the 
antiserum mixture at a concentration of 50mM before incubation of the blot. 
5. Antisera 
For immunoblot and/or EMSA analyses we used antisera specifie for various human proteins. 
The NRF1, NRF2, MafK (Santa Cruz), H01 (Stressgen), Acitn Beta (ACTB) (SIGMA) 
antisera, Ild3 (H-4) sc-1643 (Santa Cruz) were obtained commercially. Generation of MafG 
antiserum has been described previously [194]. The following dilutions where used for the 
antisera: ACTB (1:10,000) (Sigma #A-5441), human MAFF (1:200), human MAFG (1:200) 
[194] human MAFK (lllg/ml) (Santa Cruz), NRF2 (1:1000), GAPDH (0.8:1000), NRF2 
(1:1000). 
5.1 Generation of MAFF antiserum 
To construct the GST -MAFF fusion protein vector we generated a human MAFF cDNA using 
the following primer pairs Bam-MAFF (5' -GTCGGATCCATGTCTGTGGATCCCCTATCC-
3') and MAFF-Eco (5'-GCAGAATTCTAGGAGCAGGAGGCCGGGCC-3'), and digested the 
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amplicon with EcoRI and BamHI. Subsequently, the product was c10ned into the EcoRI and 
BamHI sites of the pGEX-2TK fusion vector (Amersham). Rabbits at Pocono Rabbit Farm & 
Laboratory, Inc. were immunized with the purified GST fusion protein comprising the entire 
164 amino acids coding region of human MAFF. Pre-immune serum was used to confirm the 
specificity of the generated antiserum to MAFF. 
5.2 Generation of NRF3 antisera 
To facilitate biochemical studies of NRF3 complexes, we raised a high-titer polyc1onal 
antiserum against a GST-NRF3 fusion protein. To this end, we generated a partial human 
NRF3 cDNA by PCR using the following oligonuc1eotides: FMG-GSTF3 
(5' -CTCGGATCCAGCCAGGCTATAAGTCAGGAT -3') and FMG-GSTR2 
(5'-CGCGAATTCAGTTTCTATCTGTGTCTTCAAG-3'). The amplicon was digested with 
EcoRI and BamHI and cloned into the corresponding sites of the pGEX-2TK vector 
(Amersham). Female New Zealand White rabbits were immunized with the GST fusion protein 
containing amino acids 306-534 of human NRF3. We chose the center portion of NRF3 as 
antigen to avoid cross-reaction of the antiserum with other CNC family members. Antiserum 
was tested in parallel with preimmune serum to confirm the specificity to human NRF3. In 
addition, we raised an antiserum specific for a peptide 
(KLHDL YHDIFSRLLRDDQGRPVNPN) in the carboxy terminus of human NRF3. The 
peptide was coupled to KLH and used to immunize female New Zealand White rabbits 
(Pocono Farms). The serum was purified using peptide coupled to Affi-Gel 10 according to the 
instructions of the manufacturer (BioRad). 
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6. EMSA experiments 
6.1 Oligonucleotide probes 
Complimentary oligonucleotides for EMSA probes were obtained from (Sheldon, Montreal, 
QC). 10 /lg of each complimentary oligonucleotide were mixed together in an Oligo buffer 
(5M NaCl, 0.5M EDTA, lM Tris pH 8.0). The mixture was then boiled for 10 min and then 
cooled down slowly to RT. Probes were end-Iabeled with [y_32p]_ATP using T4 polynucleotide 
kinase. The stress response element (StRE) DNA binding site oligonucleotide derived from the 
human HO-l promoter [126]. A 1200 molar excess of unlabeled oligonucleotide was used for 
competition. The NF-E2 binding site oligonucleotide derived from the human porphobilinogen 
deaminase promoter [52]. A 400 molar excess of unlabeled oligonucleotide was used for 
competition. 
6.2 Binding reaction and Specifie supershift 
For electrophoretic mobility shi ft assay (EMSA) experiments using the StRE binding site, 
nuclear extracts were prepared using the NB buffer described above. The reaction was 
incubated at 4°C for 30 min in the binding reaction containing 18 mM HEPES-KOH (pH 7.9), 
80 mM KCL, 2 mM MgCL2, 10 mM DTT, 10% glycerol, poly( dI-dC) 160 /lg/ml, 0.2 mg/ml 
bovine serum albumin and 7K-30K cpm [y_32p]_ATP labelled probe [126]. For the se supershift 
experiments 3/l1 of either preimmune or immune serum was added to the reaction mixture as 
indicated. For EMSA experiments using the NFE2 binding site, nuclear extracts were prepared 
as described previously [195]. The reaction was incubated at RT for 20 min in the binding 
reaction containing 20 mM HEPES-KOH (pH 7.9), 60 mM KCL, 60 mM MgCL2, 0.2 mM 
EDTA, 100 mM DIT, 10% glycerol, poly(dI-dC) 70 /lg/ml and 7K-30K cpm [y_32p]_ATP 
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labelled probe [196]. For the se supershift experiments l J..lI of either preimmune or immune 
serum was added to the reaction mixture as indicated. Reaction mixtures were analyzed by 
native 5% polyacrylamide gel electrophoresis and autoradiography. 
7.FACS 
7.1 Detection of intracellular H20 2 1eveis 
Intracellular H202 is detected wh en membrane-permeable 2', T-dichlorofluorescin diacetate 
(DCFH-DA) undergoes non-specifie cleavage by intracellular esterases, and the resulting 
DCFH is oxidized to the fluorescent compound, 2', T-dichlorofluorescein (DCF) in the 
presence of H20 2 as previously described [197]. JAR cells were seeded at 2x 105 cells/ml in 
six-weIl plates and were treated the following day with 5 J..lM As20 3 for 6 hours. Cells were 
then treated with 25 J..lg/ml DCFH-DA, and incubated at 37°C for 45 min. Positive control 
groups were treated with 1 mM H20 2, and incubated at 37°C for 15 min prior to time of 
collection (data not shown). The fluorescent intensity of DCF was then measured with a 
Coulter flow cytometer. 
8. Northern Analysis 
8.1 RNA Isolation 
Total RNA was prepared by usmg the TRlzol reagent (Invitrogen) according to the 
manufacturer' s instructions. 
8.2 Northern Blotting 
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Northem blotting was performed using standard procedures loading 10 Ilg of RNA per lane. 
After subjecting RNA to gel electrophoresis, the gel was transferred ovemight using standard 
techniques. The membrane was then the briefly equilibrated in EQ buffer (50mM P04 pH 7.2) 
at 65°C and pre-hybridized for 1 hour in Church buffer (0.5M P04, 1 mM EDT A, 7% SDS) at 
65 oc. The denatured labelled probe was than added to the membrane and left to hybridize 
ovemight. Finally, the membrane was washed using WB buffer (50mM P04, pH 7.2,1% SDS) 
at 65 oC [198] and analyzed using autoradiography. 
8.3 eDNA Probes 
The random priming labelling kit (Roche) was used to label all cD NA probes. To obtain a 
NRF3 -specific probe a 950 bp BgIlI fragment of human NRF3 cDNA was isolated. Human 
GAPDH cDNA was purchased (Clontech) or recovered by RT-PCR using the following 
pnmers hGAPDH-B (5'-CCACAGTTTCCCGGAG-3') and GAPDH-T 
(5'-GCTGAGT ACGTCGTGG-3'). 
To obtain PTGS2, NRF2, MAFG, MAFF- and MAFK -specific probes for Northem analysis, 
we performed an EcoRI digestion of the pCRBluntlI- COX-2, pCRBluntlI- NRF2, 
pCRBluntlI- MAFG404, pCRBluntlI- MAFF and pCRBluntII- MAFK plasmids, respectively. 
9. Two-hybrid sereen 
A Matchmaker (Clontech) two-hybrid screen was performed according to the instructions of 
the manufacturer. Human MAFG cDNA comprising the entire coding region was subcloned 
into the EcoRI and BarnHI sites of the pGBT9 vector coding for the GAL4 DNA-binding 
domain. The pGBT9-MAFG vector was introduced into HF7c cells. Subsequently, a pGAD10 
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vector-based placental Matchmaker library (Clontech), containing cDNA sequences fused to 
the GAL4 activation domain, was transformed into the HF7c (pGBT9-MAFG) ceUs. The 
transformation mixture was then plated on Trp-, Leu- , His- selection plates. Twenty-two of 80 
colonies showed lacZ activity. The cDNA insert of Il independent clones was recovered by 
polymerase chain reaction (PCR) and sequenced. The sequence of 7 clones corresponded to 
that of NRF2 and one to a cDNA of unknown function. The remaining 3 clones were identical, 
and contained nucleotides 735 to 2827 of the NRF3 gene fused to the GAL4 activation domain. 
One of the clones, 2Hyb-33, was further characterized. The S'end of NRF3 mRNA (clone RT-
PlaSpr) was recovered by standard RT -PCR, in the presence of 10% DMSO, using human 
placental RNA as template. To this end, we designed specifie primers, located upstream of the 
putative start codon using sequence data from human BAC clone (#CTB-119C02) and in the 
second exon of the NRF3 gene: hNRF3-5'FI (5'-GTGGCTCCTTCTTCGCTTCT-3') and 
hNRF3-5'R1 (5'-CAGTGGTCTTTTCTGCCTCC-3'). 
10. Dual-Luciferase Reporter Assay System 
Luciferase activity was determined with a dual luciferase reporter gene kit (DLR) from 
Promega according to the manufacturer's manual. The cells lysates were analyzed with a 
Lumat LB9507 luminometer (EG&G Berthold, Wellesley, MA, USA) after automatic injection 
of the necessary substrate solutions. AlI samples were measured at least in duplicate. The 
results for firefly luciferase activity were normalized to Renilla luciferase activity. 
11. Quantification and statistical analysis 
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Quantification of experiments was performed using a phosphoimager (Molecular Dynamics) 
and Image Quant software (version 5.2) or densitometry using NIH image software (version 
1.63). AlI data are expressed as the mean ± SEM and were analyzed using as stated either one 
way ANOVA or student T-test or non linear regression analysis. Values of P<O.05 (*) or 
P<O.Ol (**) were used as criteria for declaring significance. FACS analysis was performed 
using Cell Quest Pro software. 
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Chapter III - ResuUs 
A. Arsenic-mediated oxidative Stress in the Placenta 
Oxidative stress caused by environmental toxicants and proinflammatory cytokines can lead to 
the pathogenesis of many degenerative and inflammatory diseases, inc1uding cancer [112], 
Alzheimer disease [133], arthritis [134] and gestational disorders [135]. ROS play a dual role 
in the female reproductive tract, in that they can be both physiologie as weIl as pathologie. 
There is growing literature on the pathological effects of oxidative stress in female 
reproduction and its involvement in causing abortions [139], preec1ampsia [140], free radical-
induced birth defects [141], and preterm labour [142]. 
Arsenic, a reproductive and developmental toxicant, is weIl known for inducing oxidative 
stress [150, 151]. It is able to cross the placenta and is believed to contribute to spontaneous 
abortions, birth defects and embryonic lethality [145-147]. However, the molecular 
mechanisms of arsenic toxicity remain poody understood. Arsenic can stimulate production of 
reactive oxygen species (ROS) [199 1999] and alters cellular sulfhydryl levels [200 G.], 
whereas glutathione depletion enhances arsenic cytotoxicity [201]. Furthermore, it has been 
weIl established and documented that NRF2 is a key player in both the constitutive and the 
indu cible expression of ARE-dependent genes in numerous in vitro and in vivo studies [91, 95, 
115-118]. 
We hypothesized that NRF2 may be involved in antioxidant response to arsenic-mediated 
stress in placental cells. We selected JAR cells derived from trophoblastic tumors of the 
placenta, as a model for our studies. 
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A.t Upregulation of NRF2 protein levels by different doses of arsenic 
We first performed dose-response experiments in the placental JAR cellline. Previous studies 
had shown treatment of osteoblast cells with arsenic trioxide, an inorganic form of arsenic, 
induced a marked increase in NRF2 levels in total celllysates within 4 h, peaking at 12 h and 
remaining elevated up to 24 h [202]. Hence, we treated JAR cells for 6 hours with different 
concentrations of arsenic trioxide. We prepared nuc1ear extracts of JAR cells and analyzed 
them in immunoblot assays using a NRF2 specific antiserum. We found that nuc1ear NRF2 
protein levels are upregulated by doses of 0.5JlM of arsenic trioxide (Fig. 15). Higher 
concentrations resulted in even stronger inductions of NRF2 protein. We noticed that at doses 
of lOJlM and higher, cells looked unhealthy as evidenced by a rounded appearance resulting in 
increased numbers of cells that were lifting off the plate, especially at longer time points. We, 
thus, chose to use 5JlM of arsenic trioxide in further experiments, as this dose resulted in a 
strong induction of NRF2 protein levels with no visible toxic effects, i.e. the cells maintained 
uniform shape and did not lift off the dish. 
A.2 Time course of Arsenic induction 
We next analyzed the induction of NRF2 following treatment of the JAR cells with 5 JlM 
arsenic trioxide by preparing nuc1ear extract at different time points. Immunoblot analysis of 
nuc1ear extracts prepared from JAR cells showed upregulation of NRF2 at all the times 
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Fig.15 Induction of NRF2 by different doses of arsenic. 
Immunoblot of nucIear extracts prepared from JAR choriocarcinoma ceIls 
exposed to different concentrations of arsenic trioxide (0.5-1 O~M) or not 
(control) for 6 hours using antisera specific for NRF2 and Actin, beta (ACTB). 
30 ~g of protein was loaded per weIl. Quantification of 3 experiments is shown. 
StatisticaIly significant differences are indicated by two asterisks (P<O.OI). 
- 103 -
- 104-
Fig.16 Time course of arsenic treatment of nuclear NRF2. 
Immunoblot of nuclear extracts prepared from JAR choriocarcinoma cells 
treated or not (control) with 5JlM arsenic trioxide for 2 to 24 hours using 
antisera specifie for NRF2. 30 Jlg of protein was loaded per well. Control 
extracts from HEK293T cells transfected with a expression vector coding for 
NRF2 or not (mock) have been analyzed in parallel. 
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analyzed, from 2 to 24 hours (Fig. 16). The highest induction levels were observed at the 6 
hour time point. 
A.3 Arsenic treatment results in oxidative stress 
H20 2 has been shown to be one of the mediators of NRF2 upregulation due to oxidative stress 
[203]. To test whether it is involved in our system, JAR cells were treated with 5f.lM arsenic 
trioxide for 6 hours, and stained with dichlorofluorescin diacetate (DCFH-DA) for detection of 
intracellular H20 2• Fluorescein-positive cells were detected using FACS analysis. We showed 
that levels of H20 2 are significantly increased in JAR cells (Fig. 17) at 6 hours following 
exposure to arsenic trioxide. 
A.4 Generation of MAFF antiserum 
Given that CNC family members including NRF2 require small MAF partners in order to bind 
to the MARE/ARE binding sites [194], we examined whether the small MAFs where regulated 
by arsenic treatment. In order to test whether MAFF is induced at the protein level, we needed 
to generate an antiserum specific for human MAFF. To this end we cloned the full human 
MatF cDNA into the pGEX-2TK fusion vector (Amersham). The purified GST fusion protein 
comprising the entire 164 amino acid coding region of human MAFF was subsequently used to 
immunize Rabbits at Pocono Rabbit Farm & Laboratory, Inc. Using immunoblot analysis, the 
antiserum was shown to specifically recognize MAFF, an 18 kDa protein, in nuclear ex tracts of 
HEK293T cells transiently transfected with an expression vector coding for human MAFF 
(Fig. 18). HEK293T cells were used due to the fact that they express very low 
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Fig.17 Intracellular H20 2 levels in choriocarcinoma cells upon exposure to 
arsenic. 
JAR choriocarcinoma cells were treated with 5JlM arsenic trioxide for 6 hOUTS, 
and stained with DCFH-DA for detection of intracellular H20 2• Fluorescein-
positive cells were detected through flow cytometry. The histogram shows the 
plot for the untreated group (unshaded) overlaying that for the treated group 
(shaded). The histogram is representative of 5 experiments. 
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Fig.18: Specificity of MAFF antiserum 
Immunoblots of whole cell extracts from HEK293T cells that are not transfeeted 
(moek) or transfected with eonstruets coding either for human MAFF, MAFG 
or MAFK. The blots were ineubated with antisera specifie for each of the small 
MAF. 20 /lg of whole cell extract was Ioaded per weIl. Small MAFs are 
indicated by an arrow. 
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levels of the small MAFs. Interestingly, even though the entire cDNA was used to generate the 
MAFF antiserum, it did not cross-react with the homologous small MAF transcription factors 
MAFG and MAFK in immunoblot assays (Fig. 18). 
A.5 Protein Analysis of the Small MAFs 
We monitored the expression of the dimerization partners of NRF2, the small MAF proteins 
MAFF, MAFG and MAFK using immunoblot analysis of nuclear extracts prepared from JAR 
cells treated with 5JlM arsenic trioxide for 2 to 24 hours. We found no induction for the small 
MAF factors MAFG and MAFK, whereas expression of MAFF was slightly upregulated, in 
particular at 2, 4,6 and 16 hours following arsenic treatment (Fig. 19A & 19B & 19C). 
A.6 Increase of NRF2/small MAF DNA binding activity 
We then proceeded to examine whether the induction of NRF2 and the small MAFs translated 
into increased DNA binding. We used EMSAs to analyze the DNA binding activities in JAR 
cells. In view of the fact that proteins in this assay remain in their native form we re-assessed 
the specificities of antisera used for this study. To this end, we transiently transfected HEK293, 
which express low levels of endogenous small MAFs, with expression constructs coding for 
NRF2 and either one of the small MAF members, MAFF, MAFG or MAFK. We subsequently 
collected the nuclear extracts and performed the EMSA. Cotransfection of NRF2 and either of 
the small MAF constructs resulted in a complex binding to a stress responsive element (StRE) 
recognition site, derived from the human HO-l promoter [126] (Fig. 20). DNA binding was 
specific, as addition of an unlabeled oligonucleotide corresponding to the recognition site 
aboli shed the interaction. The NRF2 antiserum disrupted the NRF2/small MAF heterodimer, 
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Fig.19 Time course of arsenic treatment of nuclear small MAF levels. 
Immunoblot of nuc1ear extracts prepared from JAR choriocarcinoma cells 
treated or not (control) with 5J.1M arsenic trioxide for 2 to 24 hours using 
antisera specifie for (A) MAFF, (B) MAFG, (C) MAFK and ACTB. 30 flg of 
protein was loaded per weIl. 
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Fig.20 Specificities of NRF2 and small MAF antisera. 
EMSA analysis of nuc1ear extracts for HEK293T cells transfected or not (mock) 
with expression vectors coding for NRF2 and either MAFF (Ieft panel), MAFG 
(center panel) or MAFK (right panel). A stress responsive element (StRE) 
recognition site derived from the HO-I promoter has been used as a probe. Non-
labeled competitor StRE oIigonuc1eotide (oIigo), preimmune serum and NRFI, 
NRF2, NRF3, MAFF, MAFG and MAFK specifie antisera were added to the 
reaction mix as indicated. Arrows indicate the position of the different 
NRF2/smalI MAF heterodimers. 
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whereas NRFI or NRF3 specific antisera did not appear to recognize the complex. As 
expected, the MAFG specific antiserum supershifted the complex containing MAFG, but also 
cross reacted with DNA binding complexes comprising MAFF or MAFK. In contrast, both the 
MAFF and MAFK antisera seem to be highly specific and recognize only complexes that 
comprise either of the se small MAF factors. 
Next, we examined the endogenous DNA binding complexes in JAR cells that had been 
exposed to 5J..lM arsenic trioxide for 6 hours. Uninduced cells showed only a minor signal, 
although this basic DNA binding activity appeared to be specific, as competition with non-
labeled oligonucleotides aboli shed this interaction (Fig. 21, left panel). Exposure to arsenic 
trioxide resulted in the induction of a pro minent DNA binding complex (Fig. 21, right panel). 
This DNA binding activity comprised NRF2, as addition of the NRF2 antiserum clearly 
disrupted the complex. In contrast, antisera specific for the highly homologous NRFI and Nrf3 
proteins did not appear to have an effect. Addition of the MAFG antiserum that cross reacts 
with all three small MAF also completely aboli shed the DNA binding complex, whereas in the 
presence of the specific MAFF and MAFK antisera, the complex did not fully disappear. Our 
results suggest that the arsenic-induced complex in JAR cells consists of NRF2/small MAF 
heterodimers (Fig. 21), in agreement with the fact that all three small MAF proteins are 
expressed in these cells (Fig. 19). 
A.7 Arsenic mediated increase of HO-l expression 
The StRE is found in several copies in the enhancer region of the HOI gene. As further 
evidence for the involvement of oxidative stress, we examined the expression of the enzyme 
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Fig.21 Induction of NRF2Ismall Maf heterodimers by arsenic in 
choriocarcinoma cells. 
EMSA analysis of nuclear extracts for JAR choriocarcinoma cells not treated 
(left panel) or treated (right panel) with 5J.lM arsenic trioxide for 6 hours. A 
stress responsive element (StRE) recognition site derived from the HOI 
promoter has been used as a probe. Non-Iabeled competitor StRE 
oligonucleotide (oligo), preimmune serum and NRFl, NRF2, Nrf3, MAFF, 
MAFG and MAFK specifie antisera were added to the reaction mix as 
indicated. The arrow indicates the position of the endogenous NRF2/small MAF 
heterodimers. 
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Fig.22 Arsenic induced upregulation of HOt expression. 
Immunoblot analysis of cytoplasmic extracts prepared from JAR 
choriocarcinoma cells treated or not (control) with 5JlM arsenic trioxide for 
various lengths of time using antisera specifie for HOI and ACTB. 30 Jlg of 
protein was loaded per weIl. 
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HOI, a target of NRF2/small MAF DNA binding complexes [126, 204]. We showed 
expression of the HOI protein is significantly induced by arsenic trioxide in JAR cells (Fig. 
22). 
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Chapter IV - ResuUs 
A. Regulation of MAFF and NRF3 in the Placental Cells and Villi 
Another major source of oxidative stress in the female reproductive system occurs at 15 to 16 
weeks of pregnancy during the time of fetal trophoblast invasion of the uterus. This is wh en the 
placenta is being linked to the maternaI decidua by anchoring chorionic villi. During normal 
placentation, trophoblast cells that originate from the outer layer of cells surrounding the 
blastocyst inner cell mass differentiate into cytotrophoblasts. These cytotrophoblasts invade the 
maternaI decidua and adjacent spiral arteries thus forming the chorionic villi. 
In view of the fact that NRF3 and the small MAFF are highly expressed in the placenta [70, 
194] (Appendix A-Fig. 1), we further explored the possible role of these transcription factors in 
the placenta. We hypothesized that investigating NRF3 and MAFF expression in the different 
cell types found in the placenta and at different stages during the gestation period would 
provide sorne evidence on their role in the placenta. 
A.1 Human NRF3 is primarily expressed in Placental Cytotrophoblasts 
First, placental chorionic villi from different stages of gestation were obtained. Briefly, 
placentas were subjected to a series of enzymatic digests, which detached cytotrophoblast 
progenitors from the stromal cores of the chorionic villi. Once detached, the cells were 
purified and total RNA isolated. We subsequently used northern blot analysis to detect NRF3 
and MAFF mRNA levels (Fig. 23A & 24A). Two human NRF3 transcripts, a major and a 
minor mRNA species of 2.9 kb and 4.4 kb, respectively, were detected, whereas the MAFF 
transcript was detected at 2.6 kb. Interestingly, it was revealed that both NRF3 and MAFF were 
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Fig.23 Expression pattern of human NRF3 transcripts in placental cells. 
Northem analysis of total RNA prepared from placental and choriocarcinoma 
cells. A, placental chorionic villi at different gestation stages (12 weeks to 
term). Quantification of NRF3 transcript levels normalized to GAPDH mRNA 
levels was done by phosphoimager analysis. B, placental fibroblasts, 
cytotrophoblast cell islands (lSL) and cytotrophoblast progenitors. C, 
choriocarcinoma cell lines BeWo and JAR. 10 Ilg of RNA was analyzed per 
lane. Human NRF3 and GAPDH transcripts are indicated. 
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Fig.24 Expression pattern of human MAFF transcripts in placental cells. 
Northem analysis of total RNA prepared from placental and choriocarcinoma 
cells. A, placental chorionic villi at different gestation stages (12 weeks to 
terrn). Quantification of MAFF transcript levels norrnalized to GAPDH mRNA 
levels was done by phosphoimager analysis. B, placental fibroblasts, 
cytotrophoblast cell islands (lSL) and cytotrophoblast progenitors. Human 
MAFF and GAPDH transcripts are indicated. 
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iexpressed throughout gestation, from at least week 12 to term (Fig. 23A & 24A). Second, the 
expression patterns in specific ceIl populations of chorionic villi were investigated. Two of the 
predominant ceIls types in placental villi, fibroblasts and cytotrophoblasts, were isolated. 
Fibroblasts make up the stromal compartment while cytotrophoblasts line the placenta and 
mediate aIl interactions between fetal and maternaI tissues. We isolated cytotrophoblast 
progenitor cells from second trimester placentas as well as cytotrophoblasts located in ceIl 
islands from early gestation placentas, which represent a population differentiating into 
invasive cells. NRF3 and MAFF transcripts were highly expressed in cytotrophoblast 
progenitors and those derived from trophoblast islands (lSL), while expression in placental 
fibroblasts was either weak or undetectable (Fig. 23B & 24B). Finally, we found that the 
human choriocarcinoma cell lines BeWo and JAR [205, 206], derived from trophoblastic 
tu mors of the placenta, also strongly express NRF3 transcripts (Fig. 23C). These results taken 
together show that, in the placenta, cytotrophoblasts are the primary source of NRF3 and 
MAFF mRNA, suggesting that this transcription factor may function in directing the 
differentiation of these cells, which is critical to formation of the fetal-maternal interface 
during normal placentation. 
A.2 Expression of human NRF3 is stimulated by TNF 
There is increasing evidence that preeclampsia arises from poor placentation due to improper 
trophoblast invasion [158]. Proinflammatory cytokines are a chief source of ROS during this 
process. In fact, TNF levels have been shown to be higher in the circulation of women with 
preeclampsia [165]. This led us to investigate whether NRF3 expression is modulated by TNF 
in JAR cells. We found a reproducible induction of NRF3 transcripts in JAR ceIls at 4, 8 and 
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16 hours following induction (Fig. 25A). Importantly, the increased human NRF3 RNA levels 
correlated with increased protein levels (2.3 fold) in TNF-treated JAR cells (Fig. 25B), which 
suggests that NRF3 may participate in late TNF mediated signaling in placental cells. 
Only a small amount of information is available on NRF3, the most recently identified member 
of the CNC family [85]. Hence, we embarked on further characterization of the dimerization, 
binding and transactivation potential of NRF3. 
A.3 NRF3 and MAFG heterodimerize and bind to NF -E2IMARE sites 
Isolation of NRF3 using a two-hybrid strategy [207] strongly suggested that NRF3 is able to 
interact with MAFG. To this end, electrophoretic mobility shift assays (EMSA) were 
performed to assess DNA binding activity and protein-protein interactions of NRF3. HEK293T 
cells were transiently transfected with expression constructs coding for human MAFG and a 
truncated form of NRF3 (525 amino acids), corresponding to the clone isolated in the 2-hybrid 
assay. We also used a cDNA corresponding to a truncated intermediate size version (607 
amino acids) as early experiments resulted only in low level expression of the full-Iength (694 
amino acid) clone. Thus, in subsequent transfection studies we used a higher amount of the 
expression vector coding for full-Iength NRF3 (694 arnino acids). Co-transfection of 
expression vectors coding for MAFG and for either of the different NRF3 versions resulted in a 
strong DNA-binding activity to the NF-E2/MARE-type recognition site, whereas in mock-
transfected cells the complex was not present (Fig. 26A). DNA-binding was specifie as 
addition of excess unlabeled oligonucleotide corresponding to the recognition site aboli shed 
the interaction. To characterize NRF3 protein complexes biochemically, a specifie antiserum 
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Fig.25 Induction of NRF3 transcript and protein levels by TNF 
A, Northern analysis of total RNA prepared from JAR choriocarcinoma cells 
that were treated, or not, with 100 ng/ml of TNF for 4, 8 or 16 hours. 10 Ilg of 
RNA was analyzed per lane. Human NRF3 and GAPDH transcripts are 
indicated. Quantification of NRF3 transcript levels normalized to GAPDH 
mRNA levels was done by phosphoimager analysis of two independent 
experiments. 
B, Immunoblot analysis of JAR choriocarcinoma cell extract treated with 
100ng/ml TNF for 16 hours. 30 Ilg of total proteins were subjected to 
immunoblotting using purified anti-peptide antiserum raised against NRF3. 
Quantification of NRF3 protein levels normalized to GAPDH protein levels was 
performed using NIH image software analysis of three independent 
experiments. Significant statistical difference is indicated by an asterisk 
(P<O.OI). 
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Fig.26 Heterodimerization of human NRF3 with MAFG. 
NFE2 DNA binding site oligonuc1eotide derived from the human PBGD 
promoter was used as a probe in an EMSA to detect NRF3 binding activity in 
nuc1ear extracts from HEK293T cells transfected with constructs coding for 
MAFG and either truncated NRF3 versions (A, 525~ B, 607 amino acids) or 
full-Iength NRF3 (C, 694 amine acids). Non-labeled competitor human PBDG 
promoter oligonuc1eotide, pre-immune serum (PI) and/or p45-, NRF3-, MAFG-, 
MAFF-, MAFK-specific antisera were added to the reaction rnix as indicated. 
Arrows indicate the position of the different NRF3/MAFG heterodimers. 
- 132-

was generated using a GST -NRF3 fusion protein comprising solely the center portion of NRF3 
to avoid cross-reaction with other CNC proteins. Indeed, the antiserum supershifted the 
NRF3/MAFG heterodimers (Fig. 26A & 26B & 26C), and did not cross-react with other CNC 
proteins su ch as p45, NRFI and NRF2 (Fig. 27B & 27 A & 20). The formerly described MAFG 
antiserum also disrupted formation of the DNNprotein complex, unique to HEK293T cells 
expressing NRF3 and MAFG proteins, confirming that this complex contained both factors 
(Fig. 26). In contrast, antisera raised against the bZIP transcription factors p45, MAFF and 
MAFK had no effect (Fig. 26). It was also confirmed that NRF3 (525 amino acids) can 
dimerize with MAFF. However, attempts to demonstrate full length NRF3 heterodimerzing 
with MAFF were unsuccessful. This can be attributed to not using the ideal MARE binding site 
for NRF3(694)/MAFF dimers. In summary, these results show that the full-Iength human 
NRF3 transcription factor can form heterodimers with small MAF proteins resulting in 
complexes that recognize NF-E2/MARE-type DNA-binding motifs. 
A.4 Analysis of endogenous human NRF3 protein expression 
As the anti-GST -NRF3 fusion protein antiserum, used in EMSA experiments, only weakly 
recognized full-Iength NRF3 protein in an immunoblot, we raised an antiserum specific for a 
peptide (KLHDL YHDIFSRLLRDDQGRPVNPN) in the carboxyl-terminus of human NRF3. 
The peptide was coupled to KLH and used to immunize female New Zealand White rabbits 
(Pocono Farms). This serum was further purified using affinity chromatography and was 
subsequently used to analyze the expression of endogenous NRF3 at the protein level in the 
BeWo and JAR celllines, as weil as in transfected HEK293T cells. Whole cell extracts from 
HEK293T cells transfected with constructs coding for the 525 amino acid, 607 amino acid and 
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full-Iength (694 amino acids) verSIOns of NRF3 were prepared and run on an SDS 
polyacrylamide gel. Immunoblot analysis revealed the presence of the corresponding protein 
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Fig.27 Specificity of NRF3 antiserum. 
NFE2 DNA binding site oligonucleotide derived from the human PBGD 
promoter was used as a probe in an EMSA to detect binding activity in nuclear 
extracts from HEK293T cells transfected with constructs co ding for MAFG and 
either A, NRF1 or B, p45. Non-labelled competitor human PBDG promoter 
oligonucleotide, pre-immune serum (PI) and/or p45, NRF1-, NRF2-, NRF3-, 
MAFG-specific antisera were added to the reaction mix as indicated. Arrows 
indicate the position of the different CNC protein/MAFG heterodimers. 
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versions, whereas in mock-transfected cells no NRF3 was detectable (Fig. 28B). In addition, 
whole celI extracts from JAR as well as BeWo cells, were analyzed and confirmed that the 
endogenous protein displayed the same apparent molecular weight (-120 kDa) as full length 
NRF3 (694 amino acids) from transfected HEK293T cells (Fig. 28). The use of preimmune 
serum yielded multiple bands, but the appearance of NRF3 protein is evident only in the 
presence of NRF3-specific antiserum (Fig. 28A & 28B). Specificity of the antiserum was 
further established by competition with the peptide antigen in an immunoblot assay (Fig. 28C). 
It was noticed that in western blot experiments, full-Iength NRF3 gave rise to shorter versions, 
migrating at a lower molecular weight. Thus, it was speculated that the faster migrating species 
may be degradation products of the full-Iength version. The shorter products observed in 
transfected HEK293T cells are not se en in the BeWo and JAR cell lines that express 
endogenous NRF3, suggesting cell-specific modifications may be needed to yield a stable full-
length NRF3 prote in. 
A.5 Human NRF3 comprises a potent transactivation domain 
To determine whether human NRF3 can act as a transcriptional activator we performed 
transfection experiments in HEK293T cells using Gal4 DNA binding domain-NRF3 fusion 
protein constructs jointly with a Gal4 DNA binding site-Iuciferase reporter vector (Fig. 29). 
Full-Iength NRF3 is able to activate approximately 6 fold when compared to HEK293T cells 
transfected with Gal4 DNA binding domain (GaI4DBD) vector (pSG424) alone (Fig. 29). A 
chimeric protein (Ga14DBD-NRF31-536) without CNC and bZIP domains showed increased 
transactivation potential and stimulated the reporter gene by 18 fold. A more drastic increase 
was observed when the first 88 amino acids of the NRF3 amino terminus were removed. 
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Fig.28 Expression of endogenous NRF3 protein. 
lmmunoblot analysis of total protein extracted from HEK293T cells transfected or not 
(mock) with expression plasmids coding for shorter versions of NRF3 (525 and 607 
amino acids), full-Iength NRF3 (694 amino acids), or from the choriocarcinoma celllines 
BeWo and JAR. HEK293T (7 Ilg), BeWo (30 Ilg), and JAR (30 Ilg) whole-cell extracts 
were subjected to immunoblot analysis. A, Preimmune control serum. B, Purified 
antipeptide NRF3-specific antiserum. To reveal the presence of the endogenous NRF3, 
the lanes corresponding to the BeWo and JAR cell extracts of the same blot have been 
exposed 4 times longer. C, Purified antipeptide NRF3-specific antiserum in the presence 
of 50 J.1M peptide antigen. To reveal possible nonspecific bands, this blot was exposed 
10 times longer than the blot A and the lanes corresponding to HEK293T cell extracts of 
blot B. Arrows indicate the position of the shorter NRF3 versions (525 and 607 amino 
acids) and full-Iength NRF3 (694 amino acids). 
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Chimeric proteins, having in common at least ammo acids 298 to 399 of NRF3, were 
extremely potent activators and induced transcription approximately 200- to 400- fold. A series 
of deletion mutants comprising different regions of the center portion of NRF3 were used to 
map the transactivation domain. We observed a drastic decrease in the transactivation potentiaI 
of chimeric protein Gal4DBD-NRF3395-536 when compared to the Gal4DBD-NRF3298_399 (Fig. 
29). In summary, our results reveal the presence of a potent transactivation domain in the 
center portion (amino acids 298-399) of NRF3, suggesting that this protein can function as a 
potent activator of gene transcription. 
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Fig.29 Mapping of the NRF3 transactivation domain. 
Gal4 DNA binding domain-NRF3 fusion constructs and the control plasmid (pSG424) 
comprising the Gal4 DNA binding domain (DBD) alone that were analyzed in transactivation 
studies. HEK293T cells were transfected with the (GaI4)s-TKlluc reporter plasmid and various 
GaI4-NRF3 chimeric expression plasmids. Firefly luciferase activity was analyzed 48h post-
transfection. Relative luciferase activity was measured as fold activation relative to the basal 
level of the reporter gene in the presence of pSG424 vector after normalization to cotransfected 
renilla luciferase activity (pRL-TK vector). The results shown are from at least three 
independent experiments each done in triplicate, with variability shown by the error bars. 
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Chapter V - Results 
A. Regulation of MAFF in Myometrium 
Our data so far had suggested an important role for the CNC members, NRF2 and NRF3, and 
MAFF in the placenta, an essential transient organ of the female reproductive system. The 
myometrium is another vital organ in this system, because during labor it becomes active and 
develops high frequency, high-amplitude contractions that are an essentiaI part of the labor 
process. The involvement of proinflammatory cytokines in the myometrium has been 
extensively investigated in the context of both normal and abnormal pregnancy and delivery. In 
fact, not only has it been shown that a systemic fetaI proinflammatory cytokine response 
(ILIB, IL6 and TNF) is followed by the onset of spontaneous preterm parturition in patients 
[208], but it has also been shown that ILIRlffNFR double knock-out mice have significantly 
lower rates of preterm delivery [184]. 
The mechanism by which inflammation may lead to labor is postulated to involve release of 
proinflammatory cytokines, which in tum stimulate prostaglandin synthesis by gestational 
tissues via the activation of prostaglandin-endoperoxide synthase 2 (PTGS2, previously known 
as COX2), thereby causing uterine contractions [184]. 
The human MAFF protein has previously been identified in a I-hybrid assay as a factor 
binding to the US-2 motif in the human oxytocin receptor (OTR) gene [69]. This, aIong with 
the fact that MAFF transcripts are highly expressed in term myometrium, compared to the 
absence of the transcript in early gestation (14 weeks) and non-pregnant human myometrial 
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tissue [69], led our hypothesis that MAFF expression may be modulated by proinflammatory 
cytokines in the myometrium. 
1.1 Preparation of primary myometrial cens 
Primary myometrial cells were derived from a myometrial tissue dissected from a patient after 
a caesarian delivery. The tissue was rinsed, cut into smaller pieces and enzymatically digested. 
After terminating the enzymatic reaction, the tissue was filtered through a sterile gauze. 
Finally, the eluate was spun and the pellet of primary myometrial cells was washed and plated 
into 6 well plates. 
1.2 Induction of MAFF by Cytokines in Primary Myometrial Cens. 
Initial experiments sought to test whether MAFF is involved in uterine gene regulation. 
Primary myometrial cells were cultured and once they reached 80% confluency were induced 
for 3 hours with ILIB (WOng/ml), IL6 (lOOng/ml) and TNF (lOOng/ml) or combinations of 
the se cytokines. The RNA was then isolated and subjected to northem analysis. Interestingly, 
MAFF mRNA levels were induced by IL 1 Band TNF, but not by IL6 (Fig. 30). 
1.3 Immortalized Pregnant Human Myometrial Cens (PHMI-31) 
To minimize the need for primary myometrial tissue obtained from patients undergoing 
cesarian section, myometrial PHMI-31 cells were acquired and used in subsequent studies. 
These cells were derived from primary myome trial cells of pregnant women undergoing 
cesarian sections but who were not in labor. Immortalization was attained through 
overexpression of the human papilloma virus E61E7 proteins [186]. The appearance of 
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Fig.30 Small MAF expression in the primary myometrial cells. 
Northem analysis of total RNA from primary myometrial cells induced for 3 
hours with ILIB (lOng/ml), IL6 (lOng/ml) and TNF(lOng/ml) or combinations 
of these cytokines lOJ-lg of total RNA per lane was loaded. MAFF and ACTE 
transcripts are indicated. 
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PHM 1-31 cells was determined by phase contrast light microscopy (Fig. 31). The morphology 
of the cells is similar to that of regular proliferating smooth muscle cells. They appear long, 
spindle shaped with a central nucleus and a sheet-like growth pattern at confluency. 
1.4 Induction of MAFF by Cytokines in PHMl-31 Myometrial Cells. 
MAFF mRNA expression in PHM 1-31 cells treated with proinflammatory cytokines was 
examined (Fig. 32). A significant upregulation of MAFF mRNA levels by TNF, and an even 
stronger induction by ILIB was found. Similar to the primary myometrial cells, treatment with 
IL6 did not result in a significant change of MAFF rnRNA levels (Fig. 32A). Combination of 
TNF and ILIB. did not increase MAFF mRNA levels further than ILIB treatment alone (Fig. 
32A). These results suggest two things; that PHMI-3I cells, aIthough immortalized, have 
conserved their myometrial phenotype with respect to cytokine responses and that perhaps the 
mechanism of action of ILIB and TNF is different from that of IL6. What was even more 
fascinating in subsequent experiments was that in contrast to MAFF, the transcript level of the 
highly homologous MAFG and MAFK genes were not induced by ILIB or TNF. Small MAF 
protein homology has made it difficult to assign specifie roles in vitro and in vivo for each of 
the factors. These results suggest that stimulation by these cytokines is specific for the MAFF 
gene (Fig. 32B & 32C). 
1.5 Regulation of MAFF expression at the transcriptionallevel 
We started by determining the dosage and time response of IL 1 B in order to detect and 
quantify the lowest concentration and earliest time by which to achieve the maximal response. 
Linear regression is often used for building a purely empirical model between stimulus and 
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Fig.31 PHMI-31 cells. 
Phase contrast image of the immortalized pregnant human myometrial cell line 
PHM31 in culture at passage 19. Magnification is 200X. 
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Fig.32 Small MAF expression in the PHMl-31 myometrial cellline. 
Northem analysis of total RNA from PHM 1-31 cells induced for 3 hours with 
ILIB (lOng/ml), IL6 (lOng/ml) and TNF(lOng/ml) or combinations of these 
cytokines 10Ilg of total RNA per lane was loaded. MAFF (A), MAFG (B) and 
MAFK (C) and ACTB transcripts are indicated. Quantification of at least 3 
independent experiments is shown. Statistically significant differences are 
indicated by one (P<O.05) or two asterisks (P<O.OI). 
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response. However, since the receptors provide a physicallimiting factor for the binding of the 
ILlB, we used nonlinear regression to de scribe the relationship between the transcript levels of 
MAFF and the concentration of ILlB. 
We induced PHMl-3l cens using ILlB between 0.005 ng/ml and loong/ml and revealed that 
0.005 ng/ml of ILlB upregulated MAFF gene expression, with maximal induction being 
reached with 0.5 ng/ml of ILlB (Fig. 33A). Time course experiments were carried out between 
15 minutes to 24 hours. These experiments showed induction of MAFF gene transcription by 
30 minutes reaching maximal levels by 1 hour. Furthermore, elevated MAFF transcript levels 
were sustained over a 24 hour period (Fig. 33B & 33C). 
In order to test whether regulation of the MAFF transcript is due to novel RNA synthesis, we 
preincubated the PHMl-3l cens with actinomycin D. Actinomycin D intercalates between GC 
base pairs of the DNA strands and thus, inhibits transcription without interfering with 
translation or DNA replication [209]. We found that actinomycin D inhibited induction of 
MAFF mRNA by ILlB (Fig. 34) suggesting regulation at the transcriptionallevel. 
1.6 Analysis of MAFF protein levels in myometrial cells. 
MAFF protein expression in whole cell extracts, nuclear and cytoplasmic extracts prepared 
from PHMl-3l cens was also analyzed (Fig. 35A). In accordance with its function as a 
transcription factor, we provide the first evidence confirming the presence of M.AFF in the 
nucleus. We also corroborated the presence of MAFG and MAFK in the nucleus (Fig. 35B & 
35C) which had been previously reported [31, 210]. FinaIly, we examined whether the 
upregulation of MAFF transcripts also leads to an increase in MAFF protein levels. Analysis of 
nuclear extracts of cytokine induced PHMl-3l cells showed that both TNF and ILlB induce 
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Fig.33 Dose response and time course of MAF F induction by cytokines. 
(A) Dose response of MAFF transcript levels to ILlB (0.005 -lOOng/ml) in 
PHMl-3l cells. lOJ.1g of total RNA per Iane was loaded. MAFF and ACTB 
(control) transcripts are indicated. Quantification of 4 independent experiments 
is shown using non linear regression analysis. 
(B) Short time course analysis of MAFF mRNA induction by ILlB (lng/ml) in 
PHMl-3l cells. lOJ.1g of total RNA per lane was loaded. MAFF and ACTB 
(control) transcripts are indicated. Quantification of 4 independent experiments 
is shown using non linear regression analysis. 
(C) Extended time course analysis of MAFF rnRNA induction by ILlB 
(lOOng/ml) in PHMl-3l cells. lOJ.1g of total RNA per lane was loaded. MAFF 
and ACTB (control) transcripts are indicated. Figure is representative of 3 
independent experiments. 
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Fig.34 Inhibition of MAFF induction by actinomycin D. 
MAFF transcript levels in control and ILIB (lng/ml) induced PHMI-31 cells in 
the presence or absence of actinomycin D. The presence of DMSO, the vehicle 
for actinomycin D is indicated. 3 independent experiments were performed with 
similar results. 
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Fig.35 Cellular localization of small MAF protein in myometrial cells. 
Immunoblot of whole cell, cytoplasmic or nuc1ear extracts prepared from 
PHMI-31 cells incubated with antisera specifie for MAFF (A), MAFG (B) or 
MAFK (C) and ACTB. 20-30 Jlg ofprotein was loaded per well. 
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MAFF prote in expression (Fig. 36A). In contras t, expression of MAFG and MAFK protein 
was not affected by cytokine treatrnent (Fig. 36B & 36C). Hence, cytokine regulation of MAFF 
rnRNA and protein is coordinate. 
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Fig.36 Small MAF protein levels following cytokine treatment. 
Immunoblot of nuclear extracts from PHMl-31 cells induced with cytokines for 
3 hours. The blots were incubated with antisera specifie for either MAFF (A), 
MAFG (B) or MAFK (C) and ACTB. 20-30 flg of protein was loaded per weIl. 
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Chapter VII 
DISCUSSION 
Oxidative stress plays a significant role in the pathogenesis of a number of disorders su ch as 
preterm labor [135] and preeclampsia [133]. Oxidative stress may be defined as an imbalance 
between cellular production of ROS and antioxidant defence mechanisms. ROS are constantly 
produced as a result of metabolic reactions in living systems. The antioxidant defence pathway 
involves the upregulation of phase II enzymes which protect against the cell against the 
damaging effects of ROS. The expression of these enzymes, including HO and NQ01, is 
dependent on the activity of the ARE present in their promoters [113, 114]. NRF2 has emerged 
as an indispensable factor in coordinating the induction of these cytoprotective genes through 
binding to ARE. However, in order to achieve its transactivation potential NRF2 requires 
dimerization with one of the members of the small MAF or JUNIFOS family [91, 95, 115-
118]. We investigated the role that the CNC and small MAF farnily members play in the 
antioxidant response and maintaining a healthy redox balance in placental and myometrial 
cells. 
1. Modulation of arsenic-mediated oxidative stress in the placenta 
We used arsenic, a known teratogen and developmental toxicant in many animal models [150], 
which is able to cross the placenta [145-147], to induce oxidative stress in JAR cells (derived 
from trophoblastic tu mors of the placenta). We established a link between arsenic exposure and 
the rapid induction of nuclear NRF2 in this placental cell line [211]. It appears that the 
expression of the small MAFF factor is also slightly induced by arsenic, whereas the levels of 
the two other small MAFs, MAFG and MAFK, are not modulated. This is of interest as the 
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small MAF proteins are highly homologous, and functional redundancy has made it difficult to 
assign specifie roles in vitro and in vivo for each of the se factors [15, 50]. In contrast, studies 
performed in HeLa cells showed that MAFG rnRNA levels are induced by arsenic [129]. Upon 
closer examination of these results, we also noticed the induction of a MAF homologous 
mRNA species by arsenic, with a transcript size corresponding to that of the MAFF gene [129]. 
Hence, it appears that regulation of the small MAFs by arsenic is cellline dependant. 
We confirmed that arsenic causes oxidative stress in our JAR choriocarcinoma cell model, as 
shown by an increase in intracellular H20 2 levels (Fig. 5). In addition, we found the expression 
of the HO 1 protein, the rate-limiting enzyme for heme de gradation and a major stress 
responsive protein is significantly induced by arsenic in JAR cells (Fig. 6). Our results are in 
agreement with earlier reports showing upregulation of HO 1 in the presence of arsenic in 
osteoblasts and macrophages [202, 212]. Furthermore, using EMSAs, we were able to show 
that arsenic treatment causes an increase in endogenous NRF2/small MAF heterodimer binding 
to the stress responsive element (StRE) recognition site (Fig. 4). The StRE is derived from the 
human HOI promoter [126] and is structurally and functionally similar to the ARE [213]. 
Cross reactivity of the antiserum raised against MAFG, MAFF and MAFK prevents us from 
drawing specifie conclusions on the nature of the small MAF forming the heterodimer with 
NRF2, but the slight upregulation of MAFF protein levels suggests that MAFF may be an 
important partner of NRF2 in the formed complex. Nevertheless, this does not exclude the 
possibility that aIl three members might be heterodimerizing with NRF2 in response to arsenic 
treatment. 
- 164-
Another laboratory has recently provided further evidence for the involvement of NRF2/small 
MAF heterodimers in arsenic-mediated oxidative stress in mou se hepa1c1c7 cell line [214]. 
Using ChIP analysis they demonstrated that arsenic treatment leads to increased binding of 
NRF2/small MAF heterodimers to the ARE enhancer of NQ01 [214]. They postulate that the 
small MAFs in the se complexes are primarily MAFK and MAFG. However, we suggest that 
this still does not exclude MAFF as a player in the response to arsenic mediated oxidative 
stress because the small MAF antiserum (Santa Cruz) used in this study recognizes all three 
small MAFs. 
Our results thus identify NRF2 as an important stress regulator in placental cells and confirm 
earlier data showing that NRF2 is involved in the response to arsenic insult in other cell types 
such as peritoneal macrophages, keratinocytes and osteoblasts [202,203,212]. 
Great strides have been made in unraveling the mechanism of NRF2 regulation. It has become 
clear that the BTB protein KEAP1 acts as a cytoplasmic repressor of NRF2 activity [113,215, 
216]. KEAPl, in association with CUL3 and the RING box protein 1 (RBX1). appears to form 
an E3 ubiquitin ligase complex that mediates the rapid degradation of NRF2 via the 
proteosome [124, 217] (Appendix A-Fig. 2). It is known that arsenic perturbs the natural 
oxidation and reduction balance through a variety of mechanisms that are involved in redox 
reactions with endogenous oxidants and cellular antioxidant systems [218]. This is of interest, 
as the redox capacities of many proteins reside in the sulfhydryl groups on cysteines. As 
proposed earlier [219], the accumulation of nuclear NRF2 may at least in part be mediated by 
modification of the sulfhydryl groups on cysteines in KEAPI by arsenic. Hence, KEAP1 
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appears to serve as a core component in the regulation of NRF2, providing at least three 
functions: as a scaffold to anchor NRF2 with the cytoskeleton filaments in the cytoplasm, as a 
CUL3 substrate adaptor to bring NRF2 into the CUL3-dependent E3 complex for 
ubiquitination of NRF2, and as a sensor to interact with oxidative/electrophilic stimuli for 
induction of target genes. 
In addition, it has been suggested by several groups that activation of NRF2 is also regulated 
by phosphorylation of this transcription factor [216]. ERK mitogen activated protein kinase 
(MAPK) activation has been shown to be required for NRF2 nuclear localization during 
pyrrolidine dithiocarbamate induction of glutamate cysteine ligase gene expression in HepG2 
cells [220]. Induction of ERK MAPKs by arsenic has been observed previously in the human 
HaCat keratinocytes and JB6 mouse epidermal celllines [221, 222]. Intriguingly, recent studies 
in our laboratory found that ERK MAPKs are activated in the presence of arsenic in our 
choriocarcinoma cell mode!. 
Hence, we can propose that the ubiquity in the environment and the pleiotropy of toxicity of 
arsenic have thus provided selective pressure for evolution of various strategies to defend 
against oxidative stress mediated by toxic environmental contaminants. 
2. Proinflammatory cytokines in the myometrium. 
Proinflammatory cytokine-driven inflammation was initially recognized as a simple allergic 
reaction. Currently, inflammation is being considered to underline pathophysiology of a much 
broader spectrum of diseases than previously expected. Recent evidence suggests that 
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proinflammatory cytokines may play an important role in the events that lead to preeclampsia 
and preterm labor, causing morbidity and mortality of the fetus and serious health 
complications for the mother [166, 167]. 
One of the mechanisms by which infection and/or inflammation is believed to lead to labor is 
involves the infection-induced release of proinflammatory cytokines, which in tum stimulate 
prostaglandin synthesis via the induction of PTGS2 activity in gestational tissue, thereby 
causing uterine contractions [184]. On the other hand, the mechanism in which inflammation 
leads to preeclampsia is believed to be attributed to incomplete trophoblast invasion [223,224]. 
This impaired placentation leads to placental hypoxia and reperfusion injury due to ischemia 
and the resultant oxidative stress triggers the release of proinflammatory cytokines and 
prostaglandins, which results in endothelial ceIl dysfunction [225]. 
These mechanisms are supported by several lines of evidence, for instance, elevated levels of 
ILIB are observed in the amniotic fluid only late in pregnancy, whereas with infection, the 
levels of ILIB, IL6, TNF and IL8 rise even further, and this increase is linked to the early onset 
of labor [167, 183]. Furthermore, the circulating levels of TNF and ILIB have been reported to 
be much more robust in preeclamptic women [226]. 
We set out to examine the involvement of sorne of the CNC and smaIl MAF family members 
in proinflammatory cytokines mediated stress in the gestational organs, the placenta and the 
myometrium. We found an intriguing new link between proinflammatory cytokine signalling 
and MAF transcription factor gene regulation in uterine smooth muscle ceIls of the 
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myometirum. In our studies, we examined the small MAF expression in the myometrial cell 
line, PHMl-31. We found that PHMl-3l cells mimic primary myometrial cells with respect to 
morphology and upregulation of MAFF in response to cytokines [227, 228] and hence provide 
a valuable model to study myometrial gene expression and function. Most importantly, our 
novel data showed that MAFF rnRNA is rapidly induced by ILlB and TNF in primary 
myometrial and PHMI-31 cells. The induction of MAFF also occurs at the protein level in the 
PHMI-31 cell line. It is of interest to note that IL6 does not modulate MAFF transcript and 
protein levels, especially when this is considered with the findings from another laboratory 
which postulate that IL6 acts downstream of IL 1 B and TNF in the inflammatory response of 
mice [229]. 
The two most prominent transcription factors responsible for the effects of TNF and ILlB are 
NFKB and API [230]. Activation of NFKB depends on the signal-induced phosphorylation of 
IKB, which initiates the conjugation of the inhibitor to ubiquitin and its subsequent degradation 
by the proteosome. The liberated transcription factor NF-kB can then translocate to the nucleus 
and activate gene expression [231]. On the other hand, activation of the API factors is 
regulated by induction of the c-JUN and c-FOS genes and by phosphorylation of both of its 
components; both levels of regulation are under the control of distinct mitogen activated 
protein kinase (MAPK) cascades [232]. 
Promoter analysis of the human MAFF gene revealed the presence of two relevant transcription 
factor binding sites (Appendix A-Fig. 3). An NFKB site, a well known downstream target for 
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ILIB [233] and TNF signalling [234] and a MARE binding site containing a core API site. 
This suggests that MAFF may be regulated by both NFKB and API. 
Experiments targeting MAPK and NFKB inhibition (Appendix B-6) were also carried out, 
however results were inconsistent. For further functional analysis, a Bacterial Artificial 
Chromosome (BAC) containing the promoter region of the MAFF gene was obtained and used 
to generate different promoter constructs (Appendix B-5) for future luciferase assays. Testing 
the se constructs with different combination of proinflammatory cytokines would help 
determine the important regions within the MAFF promoter that are required for ILIB and 
TNF signal transduction. 
ChIP assays would also be a great tool to verify the composition of the DNA binding sites 
found in the MAFF promoter. Furthermore, using MAFF dominant negative and wild type 
MAFF overexpression plasmids generated by our lab (Appendix B-2) should provide even 
more cIues on the exact role the CNC and small MAFs may play in the response to 
proinflammatory cytokines mediated oxidative stress. 
3. Proinflammatory cytokines in the Placenta. 
In this respect, it is of interest to note that just like MAFF, we found that NRF3 mRNA and 
protein expression is also upregulated by the proinflammatory cytokine TNF in placental cells. 
The actions of TNF in pregnancy are not weil understood, but there is evidence that it may play 
an important role in placental biology. For example, both placental cytotrophoblasts and 
choriocarcinoma cell lines express members of the TNF receptor superfamily suggesting an 
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autocrine ro]e for this cytokine [235]. Furthermore, circulating levels of TNF are elevated in 
preeclampsia [161], which could contribute to this syndrome that is characterized by maternaI 
high blood pressure and proteinurea. Increased TNF levels have also been observed in 
pathological placental tissue derived from intrauterine growth restricted (IUGR) pregnancies 
[164,236]. 
Speculation on the role NRF3 may play in the placenta arose after viewing the expression 
pattern of NRF3. In contrast to the widely expressed NRFI and NRF2 genes, NRF3 transcripts 
are primarily present in the placenta (Fig. 6), aIthough they are expressed at lower levels in a 
series of other tissues [85]. This data hinted at a possible function for NRF3 in the placentaI 
TNF signaIling cascade and led us to further explore the possible role of the NRF3 
transcription factor in the placenta. 
We found NRF3 rnRNA is expressed in placental chorionic villi throughout gestation, from at 
Ieast week 12 to term [207]. NRF3 mRNA is thus present during the period when fetal cells 
penetrate maternaI tissue and develop connections with the maternaI vasculature, a process 
termed endovascular invasion, that takes place during the first half of pregnancy [237]. 
As placenta] chorionic villi are made up of multiple ceIl types including cytotrophoblasts, 
syncytiotrophophoblasts, fibroblasts and macrophages among others, we performed additionaI 
analyses in specifie cell types. We found that high NRF3 transcript levels are present in 
cytotrophoblast progenitor ceIls and in cytotrophoblasts from ceIl islands, representing ceIls 
that are differentiating down the invasive pathway. In contrast, the stromal component, 
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placental fibroblasts, do not or only minimally express NRF3 transcripts [207]. Interestingly, 
we also observed a similar pattern of MAFF expression to that of NRF3 (Fig. 25). AdditionaIly, 
we were the first to show that MAFF heterodimerizes with NRF3 and binds to NFE2/MARE 
binding sites (Fig. 26C), allowing us to speculate that NRF3/MAFF heterodimers may be 
involved in essential cytotrophoblast functions or possibly in the molecular mechanisms that 
specify important cell fate decisions that include acquisition of tumor ceIl-like invasiveness. 
Besides NRF3, other transcription factors also belonging to the API family are expressed in 
specific placental ceIltypes, for example cytotrophoblasts switch from expressing c-JUN to 
JUND as they differentiate and invade the uterine wall [156]. JUNB deficient mice die of 
placental abnormalities during embryogenesis in part due to defects in the spatial distribution 
of trophoblast giant cells, which correspond to the invasive cytotrophoblasts in the human 
placenta [238]. As it has been shown that NRF2 can interact with JUN proteins [239], it is 
probable that NRF3 may interact with other members of the API family in the placenta to 
regulate specific target genes. 
What are the potential target genes of transcription factors in placental ceIls? Like aIl tissues, 
placental development involves cell proliferation, differentiation and apoptosis [240]. We 
hypothesize that genes that play important roles in placental function, such as placental 
hormones like placental lactogen, may represent possible NRF3 targets [240]. In addition, 
matrix metalloproteinases (MMPs) such as MMP9 that are essential for the degradation of 
extracellular matrix and thus for tissue invasion, are highly regulated in the placenta [156]. In 
this context, it is interesting to note that both, placental lactogen and MMP9 can be regulated 
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by API transcription factors as indicated by the presence of typical API regulatory sequences 
in their promoter regions [241,242]. As CNC/small MAF heterodimers can bind to a subset of 
API like recognition sites, these genes may be potential targets for NRF3. 
Our simplified hypothetical model (Appendix A-Fig.4) depicts the CNC family members, 
NRF2 and NRF3, and MAFF playing a central role in maintaining the redox balance in 
myometrial and placental cells. In the placenta, MAFF heterodimerizes with NRF2 in order to 
upregulate phase II detoxifying enzymes su ch as NQOl and HOL In the myometrium MAFF 
may heterodimerize with one of the se CNC members and prevents ROS from reaching 
dangerous levels and thus allowing myometrial muscles to remain in quiescent state until the 
fetus fully matures and is ready to be delivered. 
On the other hand, our hypothetical model (Appendix A-fig. 4) illustrates that in conditions 
where exogenous sources of ROS or inflammation, su ch as environ mental arsenic 
contamination or bacterial LPS infection, lead to increased amounts of ROS generation tipping 
of the balance that the CNCIMAFF heterodimers struggle to maintain. Once overpowered the 
effects manifest into overproduction of PTGS2 and hence early muscle contractions or in the 
case of placenta poor placentation and hence the clinical symptoms of preeclampsia. 
In conclusion, we provide here the first evidence that NRF2/small MAF complexes may also 
play a role in the cellular stress response in placental cells. This is important as arsenic appears 
to cause developmental toxicity leading to spontaneous abortions, birth defects and embryonic 
lethality [145-147]. We also suggest a possible role for NRF3 and MAFF in the control of 
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transcriptional events in placental and myometriaI ceIls in response to proinflammatory 
cytokines. This is important because of the possible role that proinflammatory cytokines may 
play in preterm and normal term labor [167]. 
Three new experimental approaches have recently emerged that will prove to be powerful tools 
that should facilitate the study of the molecular signaI transduction pathways involved in 
premature labor and preeclampsia, respectively. The first approach established by Zingg et aI. 
consists of layering non-transformed human myometrial cell lines on a collagen lattice and 
then assessing the surface area of the lattices before and after treatments. This system allows 
for the direct assessment of muscle contractions. Furthermore, it would be interesting to 
investigate effects of transfecting the MAFF dominant negative and the wild type MAFF 
overexpression plasmids and observing the effects that they may have on myometriaI 
contractions. We can speculate that whereas MAFF dominant negative might lead to muscle 
contractions, the overexpression of MAFF would be concentration dependant. 
The second approach, involves the activation of soluble fms -like tyrosine kinase 1 (sFLT1). 
sFltl, a splice variant of the vascular endothelial growth factor (VEGF) receptor FItl lacks the 
transmembrane and cytoplasmic domains, and acts as a potent VEGF antagonist [243]. There is 
circumstantiaI evidence that antagonism of VEGF may have a role in hypertension, proteinuria 
and angiogenesis [244, 245]. 
Another interesting model to use is the BPHl5, which is an inbred mouse model of 
preeclampsia with borderline hypertension before pregnancy [246]. BPHl5 mice develop 
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hypertension, proteinuria, and endothelial dysfunction during late gestation. The mice, like 
humans, are more likely to have impaired placent al development and their fetuses are smaIler, 
further making them a good model for the research. 
It would be intriguing to examine the regulation of NRF3 and MAFF factors in the se mice 
during different stage of gestation. Furthermore, one can study the involvement of these factors 
after using an oral treatment of an antioxidant such as Tempol, which has been shown to 
prevent the onset of preeclampsia in pregnant mice (Hoffmann et al., 2006 unpublished). 
Therefore, using these systems to test the involvement of the CNC and small MAF members, 
might help in the quest to understand the cause, as weIl as to test preventative and therapeutic 
strategies in the management of premature labor and preeclampsia. 
The biological mechanisms by which ROS exerts their harmful activities are still not weIl 
understood at this time. To completely assess the potential their adverse health risks in various 
exposure situations, it is important not only to understand their mechanism(s) of actions but 
also the mechanisms in which the body responds to its toxic effects. This research should 
eventually lead to a better understanding of the molecular mechanisms goveming CNC/small 
MAF factors-mediated regulation of gene expression and help to uncover their possible 
functions in gestational disorders. 
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Chapter VII 
Contributions to Original Knowledge 
The results presented in this thesis have shed a new light on the role of the CNC family 
members, NRF2 and NRF3 in the placenta. These studies are the tirst to link the small 
MAF family member MAFF to proinflammatory cytokine signalling which plays a major 
role in oxidative stress which contributes to many human diseases. The candidate's major 
contributions to original knowledge are summarized below: 
1. The candidate was the first to identify endogenous NRF2/small MAF heterodimers DNA 
binding in response to arsenic in placental cells. 
2. The candidate was the first to show full length NRF3/MAFG heterodimers bind the 
NFE2/MARE binding site (Fig. 26C) and is also the first show that MAFF heterodimerizes 
with p45, NRF1, NRF2 and NRF3525 and that the se heterodimers bind to NFE2/MARE 
binding sites (Appendix A-Fig. 5). He also demonstrated the presence of the CNC 
members' transcripts (NRF 1, NRF2 and NRF3) in the PHM 1-31 cellline (Appendix A-Fig. 
6). 
3. The candidate provides the first evidence that CNC/small Maf complexes may also play a 
role in the cellular stress response in placental cells. Furthermore, his results are in 
agreement with earlier reports showing upregulation of HOI in the presence of arsenic. He 
is the first to reproduce this in placental cells. 
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4. The candidate demonstrated that proinflammatory cytokines regulate MAFF, and that this 
regulation occurs at the transcriptionallevel in uterine smooth muscle cells. 
5. The candidate was the first to generate specifie human MAFF antisera and to confirm the 
presence of MAFF protein in the nucleus. 
6. Finally, the candidate also aided in determining that globin gene activation by heme is 
independent of the putative HRMs in the p45 subunit of the NFE2 transcription factor by 
showing that the mutated versions are expressed and can still recognize a NFE2 DNA 
binding element. 
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Chapter VIII (Appendices) 
Appendix A: Results 
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Appendix A-Fig. 1 MAFF gene expression 
MAFF transcript levels in various human tissues and celllines. 
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Appendix A-Fig. 2 NRF2 Regulation Model 
Involvement of NRF2 in ARE-mediated transcription obviates the involvement of the small 
MAF partners in order to bind to the ARE sequence. NRF2/small MAF heterodimers are 
involved in the regulation of detoxifying enzyme genes and in the response to oxidative stress. 
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Appendix A-Fig. 3 MAFF Promoter Analysis 
Nucleotide Sequence of the human MAFF promoter region. Location of potential 
response elements in the 5' - flanking resion are marked. (*) Asterix indicates the 
transcriptional start site. 
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Appendix A-Fig. 4 Hypothetical Model for CNC/SmaU MAFs network in the 
Myometrium and the Placenta. 
The CNC farnily members, NRF2 and NRF3, and MAFF playing a central role in maintaining 
the redox balance in myometrial and placental cells. In the placenta, MAFF heterodimerizes 
with NRF2 in order to upregulate phase II detoxifying enzymes su ch as NQOl and HOI. In the 
myometrium MAFF may heterodimerize with one of these CNe members and prevents ROS 
from reaching dangerous levels and thus allowing myometrial muscles to remain in quiescent 
state until the fetus fully matures and is ready to be delivered. 
On the other hand, when exogenous sources e.g. arsenic contamination or bacterial LPS 
infection lead to an increased amounts of ROS generation they tip the redox balance. The 
effects manifest into overproduction of PTGS2 and hence early muscle contractions or in the 
case of placenta poor placentation and hence the clinical symptoms of preeclampsia. 
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Appendix A-Fig. 5 Heterodimerization of human CNC family members with MAFF. 
NFE2 DNA binding site oligonuc1eotide derived from the human PBGD 
promoter was used as a probe in an EMSA to detect binding activity in nuc1ear 
extracts from HEK293T cells transfected with constructs coding for MAFF and 
either A, p45; B, NRFI C, NRF2, D, NRF3 (525). Non-labeled competitor 
human PBDG promoter oligonuc1eotide, pre-immune serum (PI) and/or p45, 
NRF1-, NRF2-, NRF3-, MAFF-specific antisera were added to the reaction mix 
as indicated. Arrows indicate the position of the different CNC proteinIMAFF 
heterodimers. 
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Appendix A-Fig. 6 CNC family members expression in PHMl-31 cells 
Northem analysis of total RNA prepared from PHMl-31 cells. NRFl, NRF2 
and NRF3 transcripts are indicated. 
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Appendix A: Results 
Mernbers of the MAF and CNC farnilies of bZIP transcription factors play diverse roles in 
rnarnrnalian gene regulation, differentiation, oncogenesis and developrnent [15, 50]. Initial 
experirnents sought to characterize the role that the MAF and CNC families play in 
erythropoiesis. Erythropoiesis is the process in which new erythrocytes are produced and 
entails the production of hernoglobin. Hernoglobin synthesis requires the coordinated 
production of herne and globin [247]. Herne is the prosthetic group that rnediates reversible 
binding of oxygen by hernoglobin. Globin, which is cornprised of two <l-chains and two ~­
chains, is the protein that surrounds and protects the herne rnolecule. In particular, studies on 
the erythroid specifie transactivator NFE2 showed that it prornotes the opening of chrornatin 
throughout the ~-globin loci [248-250]. Furthermore, it has been reported that even though the 
binding of RNA polyrnerase II to the LCR is independent of NFE2, its recruitrnent to the 
hyperacetylated ~-globin prornoter requires NFE2 [251]. We showed that induction of ~-globin 
gene transcription in CB3 cens by hernin (a forrn of herne) is dependent on the presence of 
NFE2. CB3 cens have proved to be a useful tool in the study of NF E2 function in erythroid 
differentiation since they do not express the p45 subunit of NF-E2 due to a Friend leukernia 
virus insertion in one allele and the loss of the other [252, 253]. Thus, CB3 cens express only 
rninirnallevels of (l- and ~-globin rnRNA. 
We proceeded to investigate the rnechanisrn of regulation of p45 by herne. Previous studies 
have shown that the CNC protein BACHl, a hornolog of p45 and a repressor of globin gene 
transcription, is a herne binding protein and is negatively regulated through the presence of 
herne regulatory motifs (HRM)s [254]. Newer evidence further supports a role for the HRMs in 
the negative regulation of rnitochondrial irnport of ALAS 1, a mitochondrial enzyme that 
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catalyzes the first step of the herne biosynthetic pathway. These findings show that mutation of 
the HRMs reverse the inhibition of ALAS l 's irnport into the rnitochondria, indicating that the 
HRMs are essential for the herne-rnediated inhibition of ALAS 1 transport into the cell [255]. 
Cornparison arnong different HRM rnotif-containing proteins previously suggested that only 
the cysteine-proline (CP) dipeptide is absolutely conserved (Appendix A-Fig. 7 A) [256]. This 
is further supported by the alignrnent of HRM sequences found in various proteins that have 
been shown to confer regulation by herne [254,256-261]. We noted two putative HRMs, both 
cornprising a CP dipeptide, in the arnino terminus of p45 that are conserved arnong different 
species at amino acids 4/5 and 66/67 (Appendix A-Fig. 7B). We performed rnutagenesis of two 
potential HRMs in p45 and found that the rnutated versions (A4, A66 and A4/ A66) are 
expressed (Appendix A-Fig. 8A) and can still recognize an NFE2 DNA binding elernent 
(Appendix A-Fig. 8B). In addition, we showed that p45 HRM mutants are able to restore 
~-globin gene transcription in CB3 cells upon induction by hemin (Appendix A-Fig. 8C). 
Contrary to our hypothesis, these results suggest that globin gene·activation by herne appears to 
be independent of the putative HRMs in the p45 subunit of the NFE2 transcription factor [262]. 
Sirnilar findings were reported in the case of he me oxygenase 2 (H02), an isoform of HOI 
which also catalyzes the conversion of herne to biliverdin and CO, and releases of free Fe2+ 
[261]. One rnay reason that in these cases, H02 and p45 rnay function as "herne sensors" in 
which herne bound by the H02 or p45 HRMs would be protected frorn degradation and that 
when the concentration of herne exceeds the binding capacity of HRMs then excess herne 
would becorne available to serve as substrate for catalysis. 
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Appendix A-Fig. 7 Putative HRM motifs in p45 NF-E2 
(A) Alignment of HRM motifs in proteins that have been reported to confer 
regulation by heme. This includes the HAPI and Bachl transcription factors as 
weIl as the enzymes aminolevulinic acid synthase l, arninolevulinic acid 
synthase 2, cytochrome Cl heme lyase and heme oxygenase 2, (B) Diagram 
illustrating the putative HRMs comprising the CP dipeptide in the p45 subunit 
of the NF-E2 transcription factor. The cysteine to alanine mutations introduced 
by site-directed mutagenesis are shown. CNC, bZIP domains are indicated. 
Conservation of the CP dipeptide in the p45 protein of different species is 
shown. 
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Appendix A-Fig.8 Analysis of putative HRMs in p45 NF-E2 
(A) Immunoblot analysis of nuclear extracts prepared from MEL cells and CB3 
cell clones stably transfeeted with the pEFlaneo expression vector without 
insert (pEF) or coding either for p45 wild-type (wt), p45-A4, p45-A66 or 
p45-A4/A66. For immunoblot analysis a p45 specifie antiserum was used [52}. 
Equal protein amounts (l ûllg) have been loaded per lane. The p45 protein is 
indieated by an arrow, (B) EMSA analysis of nuclear extracts from MEL eells 
and CB3 cell clones. An oligonucleotide corresponding to the NF-E2 in the 
porphobilinogen deaminase promoter has been used as a probe. Non-Iabeled 
NFE2 binding site eompetitor oligonucleotide (oligo), pre-immune (PI) or anti-
p45 NF-E2 serum (a-p45) was added to the reaetion as indicated, (C) Northem 
blot analysis of total RNA prepared from MEL cells and CB3 cells clones. 1 ûllg 
of total RNA was loaded per Iane. fJ-globin and ACTB transeripts are indicated. 
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Appendix B: Materials and Methods 
The candidate has also generated plasmids and optimised assays that although yielded no 
publishable results will be essential for future studies. 
1. Ribonuclease Protection Assay plasmid Constructs 
339BAC: We preformed a PCR using the Bacterial Artificial Chromosome (BAC447C4 MP1) 
DNA, which was obtained from a source in the United Kingdom. The primers used were 
339Fl "33951BAC" (5'-
CCTTTTGTGTCCCGATCCTA-3') and 339Rl" 33613BAC" (5'-
CGTAGCCACGGTTTTTGAGT-3'). The fragment was then cloned directly into pCRBluntII. 
2. Dominant Negative and Overexpression plasmids. 
The dominant-negative MAFF mutant was constructed by overlap extension using PCR. The 
fulliength human MAFF fragment was obtained by performing RT-PCR on PHMI-31 total 
RNA using MAFF-F2 (5'-GGGCACCTTCTGCAAACATGT-3') and MAFF-R2 
(5' -GAGGCGGCGCTCAGGCACTTT-3'). The fragment was then cloned into pCRBluntII 
yielding the pCRBluntII P-31hMAFF plasmid. Mutant oligonucleotide primers used in the 
PCR were as follows: hMAFFDomNeg F4 (5'-
GGCGCCGCACACTCGCCGCGGCTGCT ACGCCG-3') and hMAFFDomNeg RI (5'-
GCGTAGCCAGCCGCGGCGAGTGTGC -3'). The resulting PCR fragment was cloned into 
the pCR-BluntII-TOPO vector (pCRBluntII) (Invitrogen) to yield pCRBluntII hMafFDN. 
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Subsequently, the MAFF dominant negative fragment was subcloned into pTRE2, pMT2 and 
pEFIa expression vectors. 
4. OTR Plasmid 
cDNA fragments were recovered by RT -PCR using these respective oligonucleotides. 
Oxytocin Receptor (OXYR): OTR-F2 (5'-GGGTCATGGAGGGCGCGCTCGCA-3') and OTR-
RI (5'-GGGTCACGCCGTGGATGGCTG-3'). Resulting amplicon was cloned into pCR-
BluntlI-TOPO vector (Invitrogen). FulIlength cDNA was used as a probe for northem blotting. 
s. MAFF Luciferase Reporter Constructs 
AlI cDNA fragments were recovered by PCR on the BAC447C4 MPI DNA using their 
respective oligonucleotides. 
651 BAC: MAFFBAC "21486"R(5' -CTGAGCCGCAGGTCGCTCTGA -3') and 
MAFFBAC"20889"F(5'-GGGCTGACGATCAGGAGCGGGTT -3'). I.1BAC: 
MAFFBAC"21486"R(5'-TGAGCCGCAGGTCGCTCTGA-3') and MafFBAC"20386"F(5'-
GACTGCTTTAACCAGGGTGGTCA-3 '). 
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6.1 NFlCB Inhibition 
Calpain inhibitor 1 (Sigma-Aldrich) was resuspended in DMSO to a concentration of 2SJlglml. 
It was then added to the cells at a concentration of (20JlM, 50JlM, l00JlM, and 20JlM) one 
hour prior to induction by ILIB. 
6.2 MAPK inhibition 
One hour prior to adding ILIB, 3JlM specifie ERK inhibitor U0126 (Promega) or SJlM p38 
inhibitor SB202190 (Calbiochem) was added to the cells. 
7. Primer Extension Analysis 
PKS229 was obtained by subcloning the fragment yielded from the digestion of PCRBI651 
with SacI into PKS. PKS229 was then linearized using Xhol and the riboprobe was produced 
using T7. 
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